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Abstract 
 
Cortical neural interfaces offer unique capabilities to researchers and 
physicians, opening doors to superior understanding and treatment of a host of 
processes and diseases in the central nervous system. One of modern 
medicine’s greatest challenges stems from the inability of the nervous system to 
heal following disease or injury, and neural interfaces combined with modern 
electronics offer significant potential to help patients regain lost function. 
Current interface technologies fall short of the long term performance that is 
necessary to be useful in the clinical setting, due in large part to the brain’s 
immune reaction to current implanted neural interface devices. This reaction 
leads to the death of neurons surrounding the implant, formation of a fibrous 
glial scar, and eventual loss of neural signals.   
This dissertation presents the results of three different studies which 
evaluated strategies to mitigate the foreign body response and its detrimental 
effects on implanted neural interfaces. Modifications were made to the 
implantation scheme, porosity, and substrate material of cortical recording 
probes, and these modifications were tested to quantify their effects on the 
foreign body response. The first study examined the relationship between 
cortical implants and the meninges, and whether the placement of the implants 
fully below the cortical surface would reduce meningeal contributions to the 
immune reaction. Sub-meninges implants were found to elicit a significantly 
reduced glial cell reaction compared to trans-meninges implants, which 
suggests the presence of a significant meningeal cell contribution to the 
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immune reaction and motivates the development of fully wireless recording 
probes which can be implanted entirely below the cortical surface.  
The second study evaluated a scheme to take advantage of the above 
phenomenon in a manner compatible with current interface technology. A series 
of holes was added to the shank of a planar neural implant near the level of the 
cortical surface, in order to allow the regrowth of meningeal tissues through the 
implant structure and discourage migration down the implant shaft. The addition 
of this feature was found to significantly reduce meningeal tissue levels and 
improve mean neuron density as well at 4 weeks post implantation.  
 In the final study, histological evaluation of a recently developed 
dynamically softening polymer neural interface substrate was performed. 
Dynamically softening implants were compared to parylene-c implants which 
possessed a similar initial modulus but lacked softening capability. The addition 
of dynamic softening capability found to significantly reduce levels of reactive 
astrocyte encapsulation at 4 weeks post implantation. 
 When combined, the results of these studies illustrate the importance of 
meningeal contributions in determining the overall characteristics of the chronic 
immune response to a cortical electrode and highlight the potential benefits of 
interventional strategies which target this portion of the immune reaction. The 
results of the final study suggest that dynamic softening capability is also a 
desirable design feature for future neural interfaces, and the combination of 
these techniques in future recording devices should yield significant 
xii 
 
improvements in neural signal quality and lifetime, according to the current 
understanding of the factors affecting neural recording array performance.  
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1 Introduction and Background 
 
1.1 Neural Interfaces 
1.1.1 Definition and brief history 
A neural interface is any device which employs electronics to monitor or 
modify activity within the nervous system. Since the initial development of such 
technologies in the 1970s, neural interfaces have played a critical role in 
furthering our understanding of the function of many systems within the CNS, 
including vision, hearing, movement, and memory. Without the highly detailed, 
real-time information provided by neural interfacing technologies, many areas of 
nervous system processing would remain poorly understood. In the past four 
decades, the development of neural interfacing technologies has followed a 
path of miniaturization, increasing capability and improving performance, not 
unlike many other modern technologies. These improvements have expanded 
the capabilities of researchers and enhanced our understanding of the nervous 
system, but the development of these technologies has an additional goal: the 
deployment of neural interfaces in human therapeutic applications. Before this 
leap from the lab to widespread use can happen, though, significant challenges 
involving the biocompatibility and service life of current interfacing technologies 
must be addressed. The focus of this work is investigating solutions to those 
challenges.  
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1.1.2 Therapeutic applications 
Restoration of nervous system function lost to disease or injury remains 
a substantial challenge for modern medicine, and this is the ultimate goal of 
neural interfacing technology development (Cheung, 2007; Lebedev and 
Nicolelis, 2006; Stieglitz et al., 2009; Welberg, 2012). Perhaps the most 
common and best known of these injury modalities is spinal cord damage 
resulting from neck or back injury, which results in partial or total loss of 
sensation and movement in some or all of the limbs. Such injuries and their 
associated functional impairments are estimated to affect 200,000 - 300,000 
individuals in the United States alone, with 12,000 new cases occurring each 
year (Qin et al., 2010). Neural interfacing technologies aim to restore function 
and quality of life to these individuals by acquiring neural signals from the CNS, 
then processing and relaying them to a variety of potential destinations, ranging 
from computer cursors to prosthetic limbs(Simeral et al., 2011; Welberg, 2012). 
Noninvasive, EEG-mediated interfacing modalities have been investigated for 
their ability to extract neural information for applications such as these, but 
these systems lack the temporal and spatial resolution necessary for the 
restoration of many physiological functions (Wolpaw et al., 2002). Such 
techniques have been successfully used to allow a subject to control a 
computer cursor, but they require significant training and concentration on the 
part of the user, and lack the necessary degrees of freedom to control more 
complex devices like prosthetic limbs (Simeral et al., 2011; Welberg, 2012; 
Wolpaw et al., 2002). Direct, cortical indwelling recording probes have already 
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demonstrated this capability in primates by directly recording signals from the 
neurons which are responsible for limb control (Batista and Andersen, 2001; 
Hochberg et al., 2006). The activity of these cells directly encodes movement 
information, and this information can only be acquired with the spatial and 
temporal resolution required for natural functional restoration via a direct cortical 
recording implant.  Since this type of probe provides the greatest range of 
potential applications, the focus of this work is the chronic indwelling cortical 
interface.  
While cortical recording probes have only seen limited experimental use 
in humans, deep brain stimulators have been approved by the Food and Drug 
Administration and have been in clinical use for more than a decade. Deep 
brain stimulation (DBS) involves the implantation of stimulating electrodes in 
specific brain regions associated with movement disorders or other conditions 
(Krack et al., 2003; Lozano et al., 2012; Romaguera et al., 2012). These 
devices use electrical pulses to interfere with neural activity in that region. 
Positioning of the electrodes in the subthalamic nucleus provides relief from the 
symptoms of Parkinson's disease (Krack et al., 2003), which is the most 
common application of this technique, but DBS has been applied in the 
treatment of other neurological conditions as well(Lozano et al., 2012; 
Romaguera et al., 2012). Although this technique differs significantly from the 
cortical recording probes which are the focus of this work, it illustrates the 
therapeutic potential of neural interfacing technology, and provides motivation 
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for further development thereof, in order to expand these exciting therapeutic 
capabilities to other brain regions and disease conditions.  
Another major area of neural interfacing therapeutic research focuses on 
the restoration of vision (Normann et al., 1999; Stieglitz, 2009). Various disease 
conditions or injuries lead to damage of the retina or optic nerve and loss of 
vision in large numbers of patients, leading researchers to begin development 
of neural interface based therapeutic strategies. Current work focuses primarily 
on the development of devices to allow researchers to better understand the 
visual processing system, as the current level of knowledge concerning visual 
processing is not sufficient to enable the deployment of a functional cortical 
vision prosthesis (Normann et al., 1999). The end goal of this work is the 
development of a stimulating interface which can be implanted in the visual 
cortex, receiving input from an externally mounted camera and image 
processing system (Brunton et al., 2012; Normann et al., 1999). In addition to 
helping elucidate visual processing mechanisms, neural interfaces have been 
used in research settings to gain large amounts of insight into other brain 
systems, including auditory processing (Sloan et al., 2009) and the motor 
system (Batista and Andersen, 2001; Hwang et al., 2012) enhancing basic 
understanding of brain function and informing future therapeutic strategies in 
these areas as well. A component of the premotor system known as the parietal 
reach region has been of particular interest to researchers, as neural activity in 
this region encodes movement intentions (Hwang and Andersen, 2010; Hwang 
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et al., 2012). Neural activity acquired from this region may be used in the 
control of computer cursors, prosthetic limbs, or other devices.  
1.1.3 Current technologies 
1.1.3.1 Microwire arrays 
Penetrating cortical electrodes have taken a few basic forms over the 
course of their development, and one of the earliest and simplest of these is the 
microwire array. Some of the earliest neural recordings were conducted using 
drawn glass micropipettes, also known as cone electrodes. These tended to 
produce very high signal-to-noise ratios (SNR), but were difficult to make and 
only permitted a limited number of recording channels (Kennedy, 1989). 
Microwire arrays are composed of metal wires, usually tungsten or stainless 
steel, in the range of 10-50 microns in diameter. The wires have an insulating 
coating, such that neural signals are acquired from the uninsulated tip of the 
wire, and each wire supports a single recording channel (Nicolelis et al., 2003; 
Prasad et al., 2012; Winslow and Tresco, 2010). Microwire arrays have the 
advantage of being inexpensive and easy to manufacture compared to more 
recently developed silicon-based architectures, which require expensive and 
sophisticated equipment and techniques borrowed from the semiconductor 
industry(Rennaker et al., 2005a). Despite their relative simplicity compared to 
silicon based arrays, microwire electrodes yield similar performance to more 
complex architectures in terms of recording channel viability and signal-to-noise 
ratio (Prasad et al., 2012; Ward et al., 2009). Microwire arrays have been used 
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to record signals from hundreds of neurons in different brain regions 
simultaneously in primates (Nicolelis et al., 2003), illustrating the adaptability 
and scalability of the technique. An example microwire array is shown in Figure 
1.1. Since the basic architecture is limited to a single recording channel per 
shaft, though, the spatial channel density of microwire arrays is typically lower 
than that of newer, silicon based architectures, which may have multiple 
recording sites per shaft (Stieglitz et al., 2009).  
 
 
Figure 1.1 
(A) Example microwire array 
(B) Several such arrays implanted in multiple brain regions in Macacamulatta 
From Nicolelis et al. 2003 
 
1.1.3.2 Utah array 
The first of the two most commonly employed silicon based neural electrode 
architectures was developed at the University of Utah and later marketed by 
Cyberkinetics as the BrainGate system (Stieglitz et al., 2009). It consists of an 
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array of penetrating spikes around 1mm in length arranged in a grid pattern and 
affixed to a base plate (Figure 1.2) (Normann et al., 1999). Recording sites are 
located at the spike tips, and the array is designed to be inserted such that the 
base plate is against the cortical surface and the penetrating spikes are fully 
inserted in the cortical tissue. The same basic architecture has taken a variety 
of forms, but the most common is a 10x10 grid of 100 spikes spaced 400µm 
apart, which is fabricated in a 3D fashion from a single block of substrate 
(Stieglitz et al., 2009). The Utah array remains the only cortical interface type to 
have been implanted in humans, beginning with a pilot clinical trial of five 
patients in 2004 (Simeral et al., 2011). This trial demonstrated the ability to 
acquire neural signals over several months, as well as the ability of tetraplegic 
patients to volitionally control a computer cursor using the neural interface 
system (Hochberg et al., 2006).  Continued functionality of the system has been 
demonstrated as long as 1000 days after implantation in the case of one human 
subject, with the 100 channel array acquiring signals from an average of 24 
individual cells at this point (Simeral et al., 2011), but viable recordings over this 
extended time period are fairly rare for all current neural electrode types.  
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Figure 1.2: The Utah silicon microelectrode array 
from Normann et al. 1999 
 
1.1.3.3 Michigan electrodes 
The final commonly used neural interface architecture is a planar silicon design 
developed at the University of Michigan and now marketed by NeuroNexus.  
Rather than the 3D architecture used in the case of the Utah Array, this design 
features planar penetrating spikes with a thickness of only 15µm and multiple 
recording sites distributed along the length of the electrode shaft (Kipke et al., 
2003). Individual shafts with up to 16 recording sites per shaft may be 
mutiplexed together to form a 3 dimensional array with as many as 1024 
recording channels and high channel density (Cheung, 2007; Stieglitz et al., 
2009). This probe design is unique among the mainstream architectures in 
9 
 
offering multiple recording channels per penetrating spike, allowing the 
acquisition of a greater amount of neural data relative to the amount of insertion 
damage caused, in addition to the ability to record from multiple cortical layers 
simultaneously. The architecture is also highly adaptable, offering an array of 
penetrating spike shapes and recording site arrangements (Kipke et al., 2008; 
Kipke et al., 2003), and even offering capabilities for integrated drug loading 
and microfluidic delivery (Chen et al., 1997; Stieglitz et al., 2009). Example 
configurations of this architecture are shown in Figure 1.3. 
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Figure 1.3: Example configurations of the Michigan planar silicon array, with 
multiple recording sites at the tip of each spike. From Kipke et al. 2008 
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1.2 The Foreign Body Response 
1.2.1 Inflammatory and scarring process overview 
The insertion of any type of invasive neural interface in the brain tissue 
initiates a complex series of events collectively known as the foreign body 
response. This process involves several types of cells, most of which are 
unique to the CNS, and results in multiple phenomena which are detrimental to 
neural interface performance. Chief among these are the encapsulation of the 
neural implant in an insulating fibrous layer, also known as the glial scar, and 
the death of neurons in the vicinity of the implant as a result of processes that 
have not been thoroughly characterized (Biran et al., 2005; Marin and 
Fernandez, 2010; Polikov et al., 2005; Stieglitz et al., 2009; Szarowski et al., 
2003). Glial scarring and neuron dieoff have been implicated as the two primary 
mechanisms of neural interface recording failure, and the mitigation of these 
phenomena is the greatest hurdle which must be overcome before neural 
interfacing technologies may become clinically viable (Polikov et al., 2005; 
Winslow and Tresco, 2010). A thorough understanding of the foreign body 
response is of critical importance to this task.   
 
1.2.1.1 Microglia 
The central nervous system is unique in the body in that it possesses its own 
population of immune effector cells that are separate from the immune system 
of the rest of the body. In the case of a large injury in the CNS with significant 
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damage to the blood-brain barrier (BBB), circulating macrophages and other 
cells may play a role in short-term inflammatory processes, but once the BBB is 
reestablished, immune processes in the CNS are characterized by two main 
native cell types: microglia and astrocytes (Biran et al., 2005; Fawcett and 
Asher, 1999; Fujita et al., 1998; Polikov et al., 2005). Both are native glial cells 
which make up most of the CNS cellular population and perform various 
structural and chemical support functions for neighboring neurons. Upon the 
initiation of an injury condition, both glial cell types in the vicinity of the insult 
change into their reactive phenotypes, which are characterized by significant 
morphological changes, proliferation, and migration (Fujita et al., 1998; 
Kreutzberg, 1996; Nakajima and Kohsaka, 2001; Polikov et al., 2005). In the 
case of microglia, this transformation initiates macrophage-like behavior, in 
which the cells phagocytose foreign material and cellular debris at the wound 
site (Fujita et al., 1998). Microglia are most active in the initial inflammatory 
phase of the foreign body response, and their activity peaks within the first few 
days following the initial injury or neural interface implantation (Polikov et al., 
2005). Reactive microglia have been shown to secrete numerous factors 
affecting a variety of processes, some of which can directly cause neuronal 
death (Nakajima and Kohsaka, 2001). Microglial activity surrounding a neural 
implant tends to decrease from about 1 week post-implantation onward. The 
remainder of the foreign body response, known as the chronic response, is 
characterized by reactive astrocytes. 
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1.2.1.2 Astrocytes 
Under normal physiological conditions, astrocytes perform many structural 
functions in the CNS, such as the formation of the blood-brain barrier and the 
glia limitans layer which ensheathes the entire CNS (Abnet et al., 1991; Fawcett 
and Asher, 1999; Kalman, 2003). The transition of astrocytes to their reactive 
morphology is accompanied by proliferation, migration, hypertrophy, and a large 
upregulation in the production of glial fibrillary acidic protein (GFAP) filaments 
(Abnet et al., 1991; Fawcett and Asher, 1999; Kornyei et al., 2000; Polikov et 
al., 2005). It is via measurement of GFAP levels that reactive astrocytes can be 
readily distinguished from their nonreactive resting state. The initiation of the 
inflammatory process causes astrocytes near the wound site to transition to the 
reactive state and migrate to the surface of the foreign body (Polikov et al., 
2005; Turner et al., 1999). In the weeks following the implantation of a neural 
interface, reactive astrocytes surround the implant and form a fibrous capsule of 
interdigitating processes commonly referred to as the glial scar (Fawcett and 
Asher, 1999; Kalman, 2003). This layer impedes the acquisition of neural 
signals by electrically insulating the recording probe from surrounding neurons, 
and this process has been implicated as one of the primary mechanisms of 
recording probe failure (Biran et al., 2005; Polikov et al., 2005; Szarowski et al., 
2003; Turner et al., 1999; Winslow et al., 2010). Example images of the glial 
scarring process are shown in Figure 1.4. Minimizing the glial scarring 
response is critical to ensuring long-term acquisition of neural signals, and thus 
GFAP expression surrounding a neural implant has become the most frequently 
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used histological metric for determining the magnitude of the chronic immune 
response to a neural implant. Measurements of GFAP expression and GFAP+ 
cellular activity will be used throughout this dissertation as one of multiple 
techniques to quantify the chronic immune response to various interfacing 
strategies. 
 
Figure 1.4: Development of glial encapsulation around an intracortical 
electrode 
(A) Acute neural injury caused by electrode insertion. Astrocytes and 
microglia become activated and migrate to the wound site. Cell nuclei 
are shown in dark blue. 
(B) Chronic response showing formation of dense sheath containing 
astrocytes and fibroblasts. From Marin and Fernandez 2010. 
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1.2.1.3 Meningeal cell contributions 
In addition to native astrocytes and microglia, previous work has indicated that 
cells derived from the meninges also contribute to the foreign body response 
(Cui et al., 2003; Fawcett and Asher, 1999; Kalman, 2003; Maxwell et al., 1990; 
Ness and David, 1997). The majority of research into the brain’s immune 
response has focused on microglia and astrocytes, but meningeal tissue and 
meningeally derived cells are known to play some role in the foreign body 
response to implanted neural interfaces. In vitro and in vivo studies have shown 
that interaction of meningeal cells with glial cells triggers the formation of a glia 
limitans and other fibrous structures which are detrimental to recording 
electrode performance (Abnet et al., 1991; Carbonell and Boya, 1988). Thus, 
the relationship of a neural interface to the meninges may prove to be an 
important aspect of device design. This will be explored further in section 
1.2.2.3 below. 
 
1.2.1.4 Effects on neurons 
The second major phenomenon of interest produced by the foreign body 
response, after the generation of the glial scar, is the death of neurons 
surrounding the implant. Neuron death has been demonstrated to accompany 
the implantation of several types of neural implants, including planar “Michigan” 
electrodes (Biran et al., 2005), polymer nanocomposite implants is (Harris et al., 
2011a), 3D silicon architectures (Seymour and Kipke, 2007), and metallic 
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mircowire implants (Thelin et al., 2011; Winslow and Tresco, 2010). It has been 
demonstrated that this loss of neurons is not only due to the mechanical trauma 
of insertion, but also due to the persistent inflammatory condition caused by the 
continued presence of a neural implant (Biran et al., 2005). One study used 
quantitative immunohistochemistry analysis to compare immune reactions to 
stab wounds and chronically implanted Michigan electrodes at 2 and 4 weeks 
post-implantation. Dramatically greater amounts of neuronal cell loss and GFAP 
expression were found in the case of electrode implants compared to stab 
wounds (Biran et al., 2005). Sample histology images from this study are shown 
in Figure 1.5, showing the distribution of the various cell types which participate 
in the immune response. IBA1+ microglia are shown in red, immediately 
adjacent to the implant, and GFAP+ reactive astrocytes are shown in green. 
Neuron death surrounding the implant is evident in a reduction in NeuN labeled 
cell bodies and a reduction in neurofilament (NF160) expression. The maximum 
radius from which a neural signal may be acquired is thought to be on the order 
of 100 microns (Biran et al., 2005; Henze et al., 2000), and the death of a large 
percentage of the neurons within this radius has been observed for multiple 
interface types (Thelin et al., 2011; Winslow and Tresco, 2010). Independent of 
the detrimental effects of the glial scarring response, the dieoff of many or all of 
the neurons within the signal-acquisition radius of a neural implant is clearly a 
major impediment to proper recording function. Widespread adoption of neural 
interfacing technologies in the clinical setting will only be practical if this 
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persistent inflammatory condition and its accompanying scarring response and 
neuronal dieoff can be significantly reduced or eliminated.  
 
Figure 1.5: Immune cell activity and neuron viability around planar silicon 
“Michigan” implants. ED1 labels macrophages and microglia, GFAP labels 
reactive astrocytes, NeuN labels neuron cell bodies and NF labels neuron 
filaments. 
(A) Combined images showing relative locations of markers 
(B) Individual markers 
From Polikov et al. 2005 
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1.2.2 Existing mitigation strategies 
1.2.2.1 Biochemical functionalization 
A diverse array of approaches has been taken in attempting to mitigate 
the brain's foreign body response and its detrimental effects on neural implant 
function. One such approach is the addition of bioactive components to the 
electrode. One study found that dexamethasone, a synthetic glucocorticoid 
hormone used to treat many inflammatory responses, was helpful in reducing 
the astrocyte response (Shain et al., 2003) and a subsequent study investigated 
the addition of a dexamethasone-eluting coating directly to the electrode, which 
was found to reduce the glial scarring response and improve neuron density 
near the implant at one and four weeks post-implantation (Zhong and 
Bellamkonda, 2007). Other bioactive components that have been added to 
neural implants include nerve growth factor (NGF) (Kennedy, 1989; Rousche et 
al., 2001) and nanoscale laminin (He et al., 2006). Many of these approaches 
have shown promising reductions in the foreign body response up to one month 
post-implantation, but the addition of a pharmacological component to the 
interface is not an ideal solution for long-term clinical mitigation of the 
inflammatory response. Release rates and concentrations of drugs are 
notoriously difficult to control over the long term, and the inflammatory condition 
may return when the concentration of the drug being released by the implant 
eventually becomes too low.  
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1.2.2.2 Coatings and surface treatments 
Another focus area of existing work is the addition of non-bioactive 
coatings or surface features to neural interfaces in order to mitigate the foreign 
body response. One such coating is parylene-c, which is an FDA Class VI 
polymer that has been used in medical devices in other areas of the body with 
good results (Hsu et al., 2009; Rodger et al., 2006; Schmidt et al., 1988). It is 
applied via a chemical vapor deposition process, which is compatible with 
commonly used neural interface architectures (Hsu et al., 2009). When applied 
to planar silicon Michigan probes, though, it was found to have no effect on glial 
cell activity or neuronal viability at 2, 4 or 12 weeks post-implantation  (Winslow 
et al., 2010). Other efforts have investigated nanoscale surface features as a 
possible route to influence the behavior of glial cells surrounding the implant 
(Moxon et al., 2007; Moxon et al., 2004; Turner et al., 1997). It has been shown 
that nanoscale surface architecture can influence the adhesion behavior of 
astrocytes in vitro (Turner et al., 1997), and nano-porous silicon surfaces were 
found to attract neurite ingrowth in vitro without impeding recording 
performance, but a detailed histological evaluation was not conducted to 
determine the effects on the immune response (Moxon et al., 2004). Although 
the techniques in this area have generally produced relatively subtle effects on 
the immune response, more work is merited to determine the ideal 
characteristics for neural interface coatings. Results from these and other 
studies are summarized in Table 1.1. 
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Study Implant 
Type 
Coating Type Result 
Winslow 2010 Michigan Parylene-C No effect on immune 
response 
He 2006 Michigan Laminin Reduced microglia and 
astrocytes, no effect on 
neurons 
Zhong 2007 Michigan Dexamethasone 
in nitrocellulose 
Reduced inflammatory 
response and neuronal 
loss 
Moxon 2004  Ceramic Nanoporous 
Silicon 
Improved neurite ingrowth 
in vitro 
Kennedy 1989 Glass cone Nerve Growth 
Factor 
NGF produced adverse 
local tissue reaction 
Table 1.1: Neural interface coatings and bioactive components with 
experimental results 
 
1.2.2.3 Implantation methods 
The manner in which a neural implant is inserted has also been shown to 
exert significant influence over the magnitude of the immune response and 
subsequent recording performance. In the case of widely-used microwire and 
silicon arrays, high speed insertion methods have been found to reduce tissue 
trauma during insertion compared to slower methods, which result in more 
deformation of the surface (Rennaker et al., 2005b; Rousche and Normann, 
1992). The method in which a neural implant is affixed after it has been 
implanted has also been shown to significantly affect the chronic immune 
response. Neural implant architectures currently in use either necessitate 
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fixation of the probe to the skull for support or sit on the cortical surface with 
relatively little mechanical connection to the skull. By comparing these two 
implantation schemes, two studies have found that skull fixation increases the 
magnitude of the chronic immune response compared to similar implants 
placed free-floating in the cortical tissue (Kim et al., 2004; Thelin et al., 2011). 
This is likely due to chronic irritation caused by relative motion between the 
brain and skull in the case of the fixed implants. One of these studies employed 
porous hollow fiber membrane implants, which are much larger than typical 
neural implants and composed of a very different material  (Kim et al., 2004). 
The second, though, employed microwire-like implants and demonstrated not 
only increased immune activity in the case of fixed implants, but also 
enlargement and elongation of the implant track voids in the rostral-caudal axis 
(Thelin et al., 2011). Free-floating implants elicited a smaller immune response 
and exhibited no void elongation. It seems likely that this elongation was due to 
relative motion between the skull-fixed implant and the brain tissue. Generally 
speaking, these studies have found that techniques which reduce mechanical 
stresses on the cortical tissue, either during implantation or the chronic 
indwelling phase, helped to mitigate the glial scarring response.  
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1.2.2.4 Flexible interface substrates 
In a further effort to mitigate the chronic inflammatory condition 
surrounding neural implants, much recent work has focused on the mechanical 
properties of the neural interface itself. Namely, studies using various materials 
in various tissues have shown that less compliant materials contribute to 
greater chronic inflammation, due to the "mechanical mismatch" between the 
implant and the surrounding tissue. Reduction of this chronic inflammatory 
reaction is thought to result in both improved recording quality and extended 
functional lifetime of the electrode. Thus, researchers have designed and tested 
neural interface architectures which utilize much lower-modulus materials than 
conventional silicon substrates. Such materials include polyimide (Cheung, 
2007; Fomani and Mansour, 2011; Mercanzini et al., 2008; Rousche et al., 
2001), an adaptive polymer nanocomposite (Harris et al., 2011a), parylene-
c(Kim et al., 2013; Takeuchi et al., 2005; Wester et al., 2009) and 
benzocyclobutene (Lee et al., 2005). In one case, improved neuron proximity to 
a mechanically adaptive neural implant was demonstrated (Harris et al., 2011a). 
These techniques still suffer from certain compromises related to the stiffness of 
the implant substrate and the ability to insert it into the cortical tissue. A 
minimum buckling strength is required in order to facilitate insertion, and this is 
usually maintained by either using a substrate that is stiffer than would be 
desired for mechanical matching with the surrounding tissue or by increasing 
the size of the implant, and thus increasing insertion trauma. One workaround 
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to facilitate implantation of a soft probe employs an insertion shuttle, but this 
also significantly increases insertion trauma (Kozai and Kipke, 2009). Also, 
although these interface substrates are significantly less stiff than conventional 
silicon architectures, they are still five to six orders of magnitude stiffer than the 
surrounding brain tissue (Ware et al., 2012). Certain types of new shape 
memory polymers, which will be covered in more detail in Chapter 4, offer 
significantly reduced stiffness compared to current flexible substrates, 
combined with dynamic softening properties which address the insertion 
strength compromise (Ware et al., 2012).  
 
1.3 Outline of experiments 
 
 The common theme of the experiments described in this dissertation is 
the investigation of novel neural interfacing techniques and materials in order to 
better understand the factors influencing the brain’s immune reaction to a 
cortical recording probe and the ways in which those factors may be 
manipulated in order to mitigate the undesirable aspects of the immune 
response. Three studies were conducted, the first two of which deal with the 
relationship between the implant and the meninges, and the influence of the 
meningeal reaction on the rest of the immune response. The third experiment 
evaluated a novel dynamically softening shape memory polymer (SMP) implant 
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substrate and measured the effects of this capability on the chronic immune 
response.  
1.3.1 Sub-meninges and trans-meninges implantation 
Previous work regarding the spatial characteristics of the cortical immune 
response which suggested the presence of a significant meningeally mediated 
component served as the motivation for the experiment described in Chapter 2, 
which sought to measure the magnitude of the meningeal contribution to the 
chronic immune response. Microwire implants placed entirely below the cortical 
surface (sub-meninges) were compared to similar implants placed in a trans-
meninges configuration, but not anchored to the skull. Multiple previous studies 
have found that implants of various types which are fixed to the skull elicit a 
greater immune reaction than similar implants which are free-floating in the 
cortical tissue, likely due to chronic perturbations caused by relative movement 
of the brain and skull (Biran et al., 2007; Kim et al., 2004; Thelin et al., 2011). 
Meningeal tissue has been shown to grow down around the shaft of a 
penetrating electrode, and the previously observed effects may be a result of 
this phenomenon as well, since the meninges-crossing aspect of the 
implantation has not been isolated from other factors by these studies (Biran et 
al., 2007; Kim et al., 2004; Thelin et al., 2011).  It is possible that the ingrowth of 
meningeal tissues and cells down the shaft of the implant contributes 
significantly to the immune reaction to a trans-meninges probe.  The study 
described in Chapter 2 was conducted in order to determine whether the 
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placement of a neural implant completely below the meninges resulted in a 
reduction in the chronic immune response by physically removing the implant 
from the meningeal space and thus reducing or eliminating the meningeal 
contribution to the immune response. A substantial reduction in both reactive 
astrocyte and microglial activity was found for sub-meninges implants, 
indicating that meningeally derived cells likely play a significant role in the 
immune response.   
1.3.2 Implant porosity 
The findings of Chapter 2 highlighted the importance of the meningeal 
contribution to the immune response, and the experiment described in Chapter 
3 sought to evaluate a method to take advantage of this immune response 
reduction technique with a method that can be applied to current wired interface 
technologies. Previous work has demonstrated that meningeal tissues can 
infiltrate the structure of a porous implant (Kim 2004), but no further 
investigation of this property had been made. Trends of decreasing immune 
activity with increasing distance down the implant shaft have been found, which 
is consistent with the hypothesis that meningeal ingrowth contributes to the 
immune response (Thelin et al., 2011; Woolley et al., 2013).  A porous implant 
structure was fabricated and evaluated to determine whether allowing 
meningeal tissue to regrow through the implant structure would reduce its 
growth down the implant shank to the recording zone. Significant reductions in 
meningeal tissue ingrowth were found for the porous implants, in addition to a 
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significant improvement in neuron density in the immediate vicinity of the probe 
compared to non-porous control implants.  
1.3.3 Dynamically softening interface substrate 
Chapter 4 describes the histological evaluation of a novel dynamically 
softening neural interface substrate. A shape memory polymer (SMP) was 
recently developed which is sufficiently stiff to facilitate insertion into the cortical 
tissue, but then softens significantly in the physiological environment following 
implantation. Several previous studies have found that lower-modulus implant 
substrates reduce the chronic immune response, but most designs suffer from 
compromises to facilitate insertion of soft flexible probes. This study was 
conducted to determine whether the dynamic softening capability of the SMP 
substrate offers beneficial reductions in the chronic immune response 
compared to another commonly used flexible interface substrate which does not 
soften. Dummy implants consisting of the SMP substrate were implanted along 
with parylene-c implants of identical dimensions to compare the chronic 
immune response.  Previous work has generally compared flexible implants of 
constant or variable modulus to very stiff controls, but this experiment fully 
isolates the effect of the dynamic softening capability by comparing the SMP 
substrate to parylene-c, which has a very similar modulus to that of the SMP 
substrate upon implantation, but does not soften. SMP implants were found to 
reduce levels of reactive astrocyte encapsulation compared to parylene-c 
controls at 4 weeks.  
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2 Sub-meninges Implantation 
2.1 Introduction  
 
The purpose of extracellular neural interfaces is to allow acquisition of 
neural signals with a high signal-to-noise ratio over a long period of time, in 
order to facilitate a wide range of therapeutic and research applications. 
Devices already in use provide relief from the symptoms of Parkinson's disease 
(Krack et al., 2003), restore hearing, or control a computer cursor or a robotic 
arm, in addition to allowing researchers to study neural processing (Stieglitz et 
al., 2009). Future neural interfacing applications include restoration of function 
lost due to CNS disease or trauma, including blindness and paralysis, and 
chronic CNS mediated control of prosthetic devices (Polikov et al., 2005; 
Stieglitz et al., 2009). Significant advances have been made in the past 30 
years towards developing a reliable cortical neural interface, but challenges still 
remain which prevent such technology from being clinically viable. Chief among 
these is the biocompatibility of the interface. Insertion of a recording implant into 
the cortex initiates short- and long-term inflammatory processes which can 
result in neuron death and eventual encapsulation and failure of the implant 
(Biran et al., 2005; Kalman, 2003; Turner et al., 1999). Numerous strategies 
have been employed to attempt to mitigate the brain’s foreign body response, 
reduce encapsulation and minimize neuronal loss, improving recording 
performance. These strategies include alterations to the probe’s size and 
shape, addition of drugs or polymers, and modification of the implantation 
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procedure (Chen et al., 1997; Cui et al., 2003; He et al., 2006; Hsu et al., 2009; 
Rousche et al., 2001; Shain et al., 2003; Williams et al., 2005). The addition of a 
dexamethasone-eluting coating was found to help reduce the astrocytic 
response (Shain et al., 2003), but a coating of parylene-c, often used in other 
medical device applications, did not affect the immune response (Winslow et 
al., 2010). Reduced implant size and elimination of conventional skull fixation 
have also been shown to reduce the immune response (Biran et al., 2007; Kim 
et al., 2004; Thelin et al., 2011).  Despite the improvements that have been 
made, the majority of recording lifetimes for many different types of interfaces 
are still on the order of several months, far short of what is necessary for a 
clinically viable therapeutic interface (Merrill and Tresco, 2005; Polikov et al., 
2005; Rennaker et al., 2005b; Shain et al., 2003). Viable recordings have been 
acquired for as long as two to three years in some cases, but such extended 
lifetimes are generally rare (Simeral et al., 2011). One common aspect of 
current array technology which has not received significant attention is the basic 
dura-crossing design of conventional wired probes. Essentially all current neural 
interfaces consist of some kind of penetrating electrode spike or wire which is 
embedded in the cortical tissue and attached to a structure and wires on the 
surface of the cortex, which convey the signal out of the skull.  
 
It has been suggested that some of the cells which participate in the 
immune response are derived from the meningeal space, in addition to the 
native astrocytes and microglia (Cui et al., 2003; Fawcett and Asher, 1999; 
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Kalman, 2003; Maxwell et al., 1990; Ness and David, 1997). The development 
of methods to prevent these cells from migrating down the electrode might 
improve chronic recording performance. In effect, meningeal cells and glial cells 
attempt to encapsulate a penetrating electrode in the same glia limitans which 
encapsulates the rest of the CNS (Fawcett and Asher, 1999). In vitro 
experimentation has shown that the formation of a glia limitans is triggered 
when astrocytes and meningeal cells come into contact, so it seems likely that 
reduction of meningeal cell migration into the area surrounding a cortical 
electrode would alleviate the glial encapsulation response (Abnet et al., 1991). 
Rapid regrowth of the dura mater has been observed during the use of chronic 
neural recording chambers in primates, often interfering with recording 
procedures and illustrating the ability of meningeal tissue to respond quickly to 
injury (Arieli et al., 2002; Gray et al., 2007). The spatial relationship between the 
meningeal space and the implant has not yet been examined for its effects on 
the encapsulation response. A study using porous hollow fiber membrane 
implants showed relatively modest immune activity despite their large size 
compared to typical neural interfaces.  It is possible that the immune response 
was minimized because of the porous nature of the implant, allowing meningeal 
derived cells to grow through the implant versus down the implant (Kim et al., 
2004). 
This study directly examines the effect of trans-meningeal implantation 
on the chronic immune response to a neural implant. For ease of availability 
and ready comparison to current technologies, microwire segments were used 
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in the current study in two implantation configurations, conventionally (trans-
meninges) and sub-meninges, in the rat cortex for a period of four weeks, and 
brain sections were subjected to quantitative immunohistochemistry analysis.   
 
2.2 Materials and Methods 
2.2.1 Subjects 
Ten male Long Evans rats were individually housed in a temperature- 
and humidity-controlled environment and were exposed to a 12:12 h light-to-
dark cycle with free access to food and water.  
2.2.2 Implants 
Implants for this study consisted of individual lengths of 50μm diameter 
stainless steel microwire with a polyimide coating. This is similar to materials 
which have been used to construct microwire recording arrays (Nicolelis et al., 
2003; Williams et al., 1999). Each animal received three sub-meninges implants 
and three trans-meninges implants. To ensure consistent implantation depth, 
insertion of the microwire implants was performed using a mechanical insertion 
device. The insertion device consisted of a 25gauge needle with a plunger wire 
inside the needle and the device was mounted to a micromanipulator. To 
perform an insertion, a microwire segment which has been sonicated in ethanol 
and rinsed with sterile saline is inserted into the end of the inserter needle with 
the plunger retracted, then the assembly is lowered, bringing the tip of the 
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implant into contact with the cortical surface. The inserter is then lowered to 
allow the implant and needle tip to incise the dura. The plunger is then 
depressed to push the implant out of the end of the inserter needle into the 
cortical tissue. Two different plunger lengths are used for the two implantation 
types – sub-meninges implants are accomplished using a plunger which 
extends to the end of the needle tip when depressed, forcing the implant 
~200μm below the cortical surface. Trans-meninges implants utilize a shorter 
plunger which leaves the end of the implant ~200μm above the cortical surface. 
A diagram of the insertion device and the two implant types is shown in Figure 
2.1.  
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Figure 2.1: Implantation Scheme 
Needle loaded with implant is positioned above implant site (1).  
Tip of implant and needle are lowered into cortical tissue through the dura (2). 
Plunger is depressed, pushing implant into tissue (3).  
Needle is retracted, leaving implant in place (4).  
Sub-meninges probes are placed approximately 200μm below the cortical 
surface. 
 
2.2.3 Surgical Procedures 
Surgical procedures are similar to those reported previously (Rennaker 
et al., 2005b). Briefly, rats were anesthetized using ketamine, xylazine and 
acepromazine (targeted dosage 50, 20, 5 mg/kg respectively). A midline 
incision was made in the scalp and the connective tissue was dissected from 
the skull.  Two bone screws were implanted into the left side of the skull to 
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secure the acrylic skull cap.  A 3 mm × 5 mm portion of the right parietal bone 
was removed using micro-rongeurs. Three microwire implants of each 
treatment were inserted in the manner described above. All subjects received 
both implant types in order to minimize the effects of animal-to-animal 
variability. Following implantation, the brain was covered by a layer of silicone 
elastomer (Kwik-Cast; World Precision Instruments, Inc., FL) and a layer of 
acrylic was added to seal the craniotomy and secure the structure to the bone 
screws. The initial incision was closed using absorbable sutures. All procedures 
were carried out in accordance with protocols approved by the University of 
Oklahoma Institutional Animal Care and Use Committee. 
2.2.4 Immunohistochemistry 
At 4 weeks post-implantation, subjects were euthanized and perfused. 
Subjects were administered 0.7 mL of the same ketamine cocktail used for the 
surgical procedure, and then transcardially perfused with 100 mL of phosphate 
buffered saline (PBS) followed by 100mL of 4% paraformaldehyde in PBS. The 
brain was removed and stored (4◦C) for 48 h immersed in a solution of 30% 
sucrose by volume and 4% paraformaldehyde for postfixation and 
cryoprotection. Both sub- and trans-meninges implants were still in the brain 
following removal of the skull.  These wires were removed from the brain prior 
to and during blocking of tissue around the implant site for sectioning.  The 
brain was cut into 40μm thick horizontal sections which were collected free-
floating in PBS.  Alternating sections were stained with antibodies for GFAP to 
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label activated astrocytes, and IBA1 to label activated microglia in both 
phagocytic and nonphagocytic forms (Jones and Tuszynski, 2002; Nakajima 
and Kohsaka, 2001; Polikov et al., 2005). All sections were also labeled with 
NF160 anti-neurofilament antibody to visualize neuronal processes surrounding 
the tracks. Following three washes in PBS, sections were blocked in 3% normal 
donkey serum for 30 minutes. Sections were then incubated overnight in 
primary antibody solutions (NF160 and GFAP or IBA-1, 1:250) in a buffer 
containing 3% normal donkey serum and 0.3% Triton X-100.  The following day, 
sections were rinsed and then incubated in secondary antibodies for 2h and 
then visualized with AlexaFluor 555 (Invitrogen) and coverslipped using 
Vectashield with DAPI (Vector Laboratories). All tissue sections in this study 
were stained at the same time with the same primary and secondary solutions 
to ensure consistency. Images were taken using an Olympus BH-2 microscope 
with a 10x objective and an Olympus DP70 digital camera. 
2.2.5 Analysis 
Images were analyzed using ImageJ software (NIH) to perform 
automated thresholding and area measurements of the activated regions 
surrounding electrode tracks for GFAP labeled images. Contralateral control 
sections were used to determine average background fluorescence levels and 
set threshold values for each cell type for each animal. Pixel count was 
converted to square microns of activated area around each track.  An example 
track is shown in Figure 2.2 with the above-threshold region outlined to 
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illustrate the area that was measured.  Due to the nature of the cells, IBA1 
labeled images could not be subjected to the same simple area counting 
method as GFAP images. Instead, a radial intensity profile function in ImageJ 
was used to measure the average fluorescence intensity as a function of radius 
from the implant-tissue interface. These intensity integrals, consisting of the 
area under the intensity curve, were then separated into 6 bins of 50μm each 
for statistical analysis. The same radial intensity profile technique was also used 
to examine GFAP labeled activity.  For all analyses except for depth 
comparisons, a single mean intensity or area value was found for each track 
across all section depths. 
 
 
37 
 
 
Figure 2.2: Typical GFAP labeled trans-meninges implant track showing area 
count border generated by ImageJ. Scale bar = 100μm. 
 
2.3 Results 
2.3.1 Astrocyte activity 
Fluorescent labeling with antibodies for glial fibrillary acidic protein 
(GFAP) was used to identify reactive astrocytes while IBA-1 antibodies were 
used to label activated microglia. GFAP labeled images exhibited regions of 
reactive astrocyte activity surrounding each implant track, forming a densely 
packed, multilayered capsule which is typical of a neural implant at a 4 week 
time point. An example track showing all 4 imaging markers is shown in Figure 
2.3. 
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Figure 2.3: Representative images of the same sub-meninges implant track at 
4 weeks with four different markers (* denotes implant location) 
A) GFAP showing reactive astrocytes; 
B) NF160 showing neuronal processes;  
C) DAPI showing all cell nuclei;  
D) IBA-1 showing activated microglia. Scale bar = 100μm 
 
2.3.1.1 Morphology 
Morphology of GFAP+ cells was consistent with that of reactive 
astrocytes in the CNS. The GFAP+ sheath surrounding each implant track was 
accompanied by a surrounding area of GFAP+ cells extending tens to a few 
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hundred microns from the implant center in a generally radially symmetric 
fashion. The GFAP+ regions surrounding the tracks were clearly delineated 
from the surrounding background, allowing the use of simple threshold-based 
software to determine the regions’ size. 
Figure 2.4 shows two example images from a single tissue section 
stained for GFAP.  The trans-meninges implant (A) and sub-meninges implant 
(B) are shown side by side for comparison. This representative sample 
illustrates the dramatic difference in GFAP expression between the two 
implantation methods.   
 
 
Figure 2.4:  Representative sample of GFAP reactivity in a single cortical slice 
to trans-meninges (A) and sub-meninges (B) implants.  Scale bar = 100μm 
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2.3.1.2 Quantitative GFAP measures 
The areas for each section were measured using Image-J. Sub-
meninges implants showed 63% less GFAP labeled cellular area on average 
than trans-meninges implants, as shown in  Figure 2.5 (t-test, n=30, p<0.001). 
A previous study (Thelin et al., 2011) found that implants tethered to the skull 
tended to form larger cavities that were elongated in the rostral-caudal axis. It is 
possible that the trans-meninges implants in the current study were 
mechanically attached to the silicone used to cover the brain following 
implantation.  This is unlikely given that we removed the wires from the brain 
after the skull was detached.  The silicone came off with the skull in most cases.   
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Figure 2.5: GFAP labeled track areas for sub-meninges and trans-meninges 
implants +/- 95%CI (*p<.001) 
 
If the trans-meninges implants were attached to the silicone, it is likely 
that an asymmetry in the wound site or GFAP response would be present due 
to relative motion between the brain and the skull. An examination of the voids 
at the center of the GFAP labeled areas found no differences in void area 
between implant types (t-test, p =0.76). Measurement of the voids’ edge-to-
edge distances in the rostral-caudal and medial-lateral directions revealed no 
significant elongation of the voids along either axis for either sub-meninges 
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(p=0.47) or trans-meninges implants (p=0.75), as shown in Figure 2.6. This 
scatter plot reveals a general grouping of the data around the line y=x, which 
indicates a circular void, and suggests that the trans-meninges implants were 
not tethered to the skull. 
 
 
Figure 2.6: Edge-to-edge dimensions of track voids for both implant types 
showing data from deepest and shallowest sections only. Line (y=x) indicates 
no void elongation in either direction. 
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The same images were also subjected to analysis via radial intensity 
profiling, in order to measure the fluorescence intensity as a function of distance 
from the implant-tissue interface and examine the spatial distribution of the 
astrocyte response. It was found that sub-meninges implants taken from the 
same cortical slice had significantly less GFAP labeled cellular activity out to a 
radius of 300μm (Figure 2.7). The intensity profile analysis illustrates both the 
reduced intensity and reduced radial extent of reactive astrocyte activity for sub-
meninges implants. The general scale of the astrocyte response is consistent 
with other histological studies using implants of this general size (Biran et al., 
2005; Winslow and Tresco, 2010). Due to imaging constraints and the proximity 
of neighboring tracks and section edges, we could not measure fluorescence 
intensity consistently any further than 300μm for the entire data set, therefore 
the measurements at 350μm are from a subset of about 1/2 of all tracks.  For 
this radius bin, though, no difference in integrated intensity was found between 
the two implant types (t-test, p = 0.057). This indicates that GFAP+ reactivity 
has returned to background levels at 350μm from the implant surface for trans-
meninges implants. ANOVA comparison of the radius bins for sub-meninges 
implants showed no difference between the 250, 300 and 350μm radii, 
indicating that GFAP+ activity has returned to background levels at a 250μm 
radius for the sub-meninges implants. Thus, the typical maximum extent of 
reactive astrocyte activity is reduced by about 100μm by sub-meninges 
implantation. 
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Figure 2.7: GFAP intensity as a function of radius for trans-meninges and sub-
meninges implants +/- 95%CI (*p<.001) 
 
2.3.1.3 Astrocyte activity by section depth 
In addition to examining mean track areas across all section depths to 
compare sub-meninges and trans-meninges implants, GFAP area data were 
grouped and analyzed according to section depth in order to better understand 
the spatial distribution of the astrocyte response. If the meningeal tissue were 
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growing down the shaft, it is reasonable to assume that the glial scar would be 
larger at the more superficial layers.  When the data from this study are 
arranged by depth, no such trend is evident (Figure 2.8). Neither type of 
implant shows statistically significant differences in astrocyte activity between 
section depths. It is likely that the elevated response near the cortical surface 
was not captured because we only compared sections in which both sub and 
trans-meninges implants were present (>200μm below the cortical surface).  
The topmost layers of the cortex were not collected due to the lack of chronic 
sub-meninges implant tracks.  Additionally, it is possible that any cellular 
migration from the cortical surface is already complete by the 4 week time point 
employed in this study. 
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Figure 2.8: Mean GFAP labeled areas grouped by section depth for sub-
meninges and trans-meninges implants 
 
2.3.2 Microglia activity 
Adjacent sections utilized IBA1 antibodies to label activated microglial 
cells, and these also showed a region of cellular activity immediately 
surrounding the implant. Cellular morphology was consistent with that of 
activated microglial cells. IBA1+ regions were much smaller than GFAP+ 
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regions for the same tracks, which is consistent with other findings that 
microglial activity peaks in the first week post-injury and astrocyte activity 
dominates from then on (Biran et al., 2005; Polikov et al., 2005). Due to the 
sometimes more diffuse nature of the microglial cellular activity and the lack of 
a well-defined border between labeled cells and unlabeled tissue, intensity 
profiling was used exclusively for analysis rather than area measurements. 
IBA1 labeled sections showed statistically significant reductions in fluorescence 
intensity for the first three radius bins of 0-150μm from the implant surface (t-
test, p<.05), as shown in Figure 2.9. There were no significant differences in 
IBA1 reactivity for sub-meninges or trans-meninges implants at radii greater 
than 200μm from the center of the electrode track. 
 
48 
 
 
Figure 2.9: IBA1 intensity as a function of radius for sub-meninges and trans-
meninges implants +/- 95% CI (*p<0.05) 
 
Both the mean intensity and the radial extent of microglia cellular activity 
were reduced by sub-meninges implantation.  Combined with the reduction in 
reactive astrocyte activity, this constitutes a large reduction in the size and 
scope of the foreign body response for sub-meninges implants, which should 
correspond to an improvement in recording array performance for sub-
meningeally implanted recording devices. 
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As with GFAP sections, no significant trend was found when IBA1 
fluorescence intensity values for the significant radius bins were compared 
according to section depth (data not shown). Given that a greater degree of 
variability was found in IBA1 labeled activity than with GFAP, a subtle trend in 
reactivity with depth is more difficult to separate from normal variation.  
2.3.3 Neurofilament results 
Visualization of neuronal processes using NF160 antibody labeling did 
not produce sufficiently consistent results for meaningful data to be obtained. 
Morphology of labeled structures was consistent with neuronal processes, 
indicating proper function of the antibody, but the degree of labeling exhibited a 
high degree of variability from track to track and section to section not seen with 
the other techniques used in this study. Some implant tracks exhibited areas of 
elevated NF160 immediately surrounding the track, as seen in Figure 2.3B. An 
increase in neuronal density immediately surrounding a track is not consistent 
with widely observed neuronal dieoff surrounding an implant (Biran et al., 2005; 
Turner et al., 1999; Winslow and Tresco, 2010), but a similar phenomenon has 
been observed by other researchers when using the NF160 antibody (Winslow 
and Tresco, 2010). Future studies will employ NeuN to label neuron cell bodies 
and better allow quantification of viable neurons around the implant site. 
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2.4 Discussion 
The results of this study suggest that the meninges play a role in 
determining the extent of the immune response at 4 weeks post-implantation.  
The data demonstrate that the immune response to a cortical implant is greatly 
reduced when the entire implant is not in contact with the meninges. The 
average amount of GFAP-labeled cellular activity, which is the primary metric of 
the chronic immune response (Kalman, 2003; Polikov et al., 2005; Szarowski et 
al., 2003; Turner et al., 1999), was nearly threefold greater for trans-meninges 
implants than sub-meninges implants (Figure 2.5).  As fibrous encapsulation by 
reactive astrocytes has been shown to be strongly correlated with neural 
recording device failure, this reduction should correspond to an improvement in 
recording device performance and signal lifetime (Polikov et al., 2005).   
Radial intensity profile analysis was also used to examine the astrocyte 
response. This revealed a reduction in both the intensity and the extent of 
GFAP labeled cells surrounding sub-meninges implant tracks. GFAP intensity 
was significantly reduced for all 6 radius bins that were measured out to a 
distance of 300 microns from the implant-tissue interface (Figure 2.6). At 
350μm, GFAP intensity had returned to the background level. The greatest 
reductions in integrated fluorescence intensity were seen in the 150μm and 
200μm radius bins, indicating a reduction in the overall extent of the astrocyte 
response in addition to the intensity reduction. This is consistent with the 
findings of the threshold-based area measurements. The reduction of mean 
astrocyte activity in this 100 micron radius zone is particularly important for 
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neural interface function, since this is thought to be the maximum radius from 
which neural signals may be acquired, and elevated GFAP+ activity has been 
shown to be negatively correlated with neuron viability (Biran et al., 2005; 
Henze et al., 2000; Winslow and Tresco, 2010).  
A reduction was also seen in areas of IBA1 labeled microglial activity. 
Microglial cell activity tends to peak around 1 week post-injury (Biran et al., 
2005; Kalman, 2003; Polikov et al., 2005) and is reduced from its peak level by 
the 4 week time point used in this study, but a thin sheath of activated cells still 
surrounds each implant track, in the same region as the activated astrocytes. 
As microglia participate primarily in the acute inflammatory phase of the 
immune response and their activity should have decreased significantly by the 4 
week time point used in this study, (Biran et al., 2005; Kreutzberg, 1996; 
Nakajima and Kohsaka, 2001; Polikov et al., 2005) the observed reduction in 
microglial activity indicates that sub-meningeal implantation likely has desirable 
effects on the acute phase of the immune response in addition to the chronic 
phase, which is characterized mainly by reactive astrocyte activity and the 
formation of the glial scar (Carbonell and Boya, 1988; Kalman, 2003). The 
reduction of microglial activity is also likely to have a desirable effect on 
neuronal viability in the region surrounding the implant, as the presence of 
these cells has been correlated with neuronal death (Biran et al., 2005). This 
may be mediated directly by a number of cytotoxic compounds that have been 
shown to be secreted by microglia which cause neuron death or alteration of 
function, including monocyte chemotactic protein-1 (MCP-1) and tumor necrosis 
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factor-alpha (TNF-α), among numerous others (Biran et al., 2005). The 
presence of IBA1+ cells in the immediate vicinity of the implant may suggest the 
existence of a persistent inflammatory state, based on findings that such 
cellular reactions are only found in the case of indwelling implants, and not in 
the case of stab wounds (Biran et al., 2005). Given the observed decrease in 
IBA1 immunoreactivity for sub-meninges implants in the current study, it seems 
likely that a reduction in chronic inflammatory activation makes up some part of 
the mechanism responsible.  
The mechanisms which may account for the observed reduction in the 
foreign body response due to sub-meningeal implantation are not fully 
understood, but there are some factors which are thought to contribute to the 
immune response which may be affected by the implant's location.  Meningeally 
derived fibroblasts have been found to migrate into the wound from the 
meningeal space and contribute to the inflammatory response (Kalman, 2003; 
Kim et al., 2004; Maxwell et al., 1990; Ness and David, 1997), and positioning 
the implant below the cortical surface may reduce this component. In one study, 
an encapsulating sheath of meningeal fibroblast cells was found surrounding 
silicon "Michigan" probes implanted in the guinea pig cortex at two weeks (Cui 
et al., 2003). In effect, these cells participate along with reactive astrocytes in 
the process of forming a new glia limitans around the implant which migrates 
down the wound track from the pial surface (Maxwell et al., 1990). Sub-
meningeal implantation of the device physically removes it from the pial space, 
and thus likely inhibits this process.   
53 
 
Placement of the implant below the meninges may reduce chronic 
micromotion between the implant and the surrounding cortical tissue, which has 
been implicated in exacerbating the chronic immune response. It has been 
shown that hollow fiber membrane cortical implants that were free-floating in the 
cortical tissue had reduced chronic immune activity compared to implants which 
were anchored to the skull (Kim et al., 2004). It is possible that the reactive cells 
grew through the membrane and not down the membrane. This suggests that 
an electrode with a porous substrate at the meninges might reduce the immune 
response. In the current study, available surgical techniques make it impossible 
to completely isolate the effects of implant location and chronic micromotion, as 
the upper ends of the trans-meninges implants are still in contact with the 
silicone elastomer used to seal the craniotomy. The amount of interface is 
small, though, and much softer than the fixation materials which have been 
employed for tethered implants to study this effect (Kim et al., 2004; Thelin et 
al., 2011). Also, the effects of tethered implantation, namely enlarged, 
elongated void areas (Thelin et al., 2011), were not present for either implant 
type in the present study. Figure 2.6 shows the distribution of track void 
dimensions along the rostral-caudal and medial-lateral axes, showing no void 
elongation or enlargement for either type of implant. Thus, it seems safe to 
conclude that chronic micromotion between the brain and implant did not play a 
large role in producing the observed difference between the implant types.  
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2.5 Conclusion 
Quantification of glial cell activity surrounding sub-meninges and trans-
meninges microwire implants revealed that sub-meninges implantation yields a 
substantial decrease in the chronic immune response to a microwire implant.  
Subdural implantation of microwire segments produced an average reduction in 
astrocyte activity of 63% compared to conventionally implanted controls. 
Microglial activity was also reduced.  This offers insight into the factors that 
govern the brain’s response to a neural implant, and these results also suggest 
that techniques which isolate implants from the meninges may reduce the 
encapsulation response and improve chronic recording quality.   
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3 Implant Shank Porosity  
 
3.1 Introduction 
The current understanding of neural recording electrode failure holds that 
the loss of neural signals is caused in large part by the fibrous encapsulation of 
the implant by reactive microglia and astrocytes (Polikov et al., 2005), although 
other mechanisms related to death or displacement of neurons near the implant 
have also been implicated in the failure of these devices (Biran et al. 2005).  
Recent work has indicated that meningeally derived cells may play a significant 
role in the inflammation and encapsulation response as well (Markwardt et al., 
2013; Woolley et al., 2013). Contact between astrocytes and meningeal cells 
has been shown to trigger the formation of a glia limitans in vitro, which 
suggests that the presence of meningeal cells around a cortical electrode would 
contribute to the fibrous encapsulation response(Abnet et al., 1991). 
Fluorescent antibody labeling of vimentin around planar silicon implants 
revealed significantly increased presence of this protein in the cellular mass 
surrounding the implant (Woolley et al., 2013). Meningeal fibroblasts and 
reactive astrocytes are known to express vimentin, but reactive astrocytes also 
strongly express GFAP, which is not expressed by meningeal fibroblasts. Since 
GFAP was not evident in the observed superficial cell clusters in this study, this 
strongly suggests the presence of vimentin-expressing meningeally derived 
fibroblasts (Woolley et al., 2013). The lack of significant IBA-1 labeling in this 
region also supported this conclusion, indicating the absence of native 
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microglia. Additionally, a trend of decreasing immune cell activity with 
increasing depth along the implant shaft was revealed, which is consistent with 
the idea of a strong meningeal component in the immune response. The study 
described in Chapter 2 compared loose microwire segments that were placed 
completely below the cortical surface to conventional meninges-crossing 
implants, and found that sub-meninges implantation produced a substantial 
reduction in the immune response at four weeks (Markwardt et al., 2013). 
These results support the hypothesis that meningeal tissue contributes to the 
chronic immune response.  
Current neural interface technologies rely upon meninges-crossing designs 
for data transmission, so although our previous study offers insight into the 
factors governing the immune response, fully sub-meninges recording probes 
are not currently technically feasible. In order to take advantage of the observed 
phenomena, other techniques must be employed to mitigate the meningeal 
contribution to the immune response and fibrous encapsulation in the recording 
region of penetrating intracortical electrodes. Ingrowth of vimentin+ meningeal 
tissue into the porous structure of a cortical implant has been demonstrated 
previously (Kim et al., 2004). This study employed porous hollow fiber 
membrane implants which showed changes in immune response as a result of 
differing implantation techniques, but hollow fiber membranes do not represent 
a viable recording electrode material and are porous the entire length of the 
structure.   
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The current experiment investigates the influence of the addition of pores in 
the region of the planar polymer implant in contact with the meninges on the 
brain’s immune response. It is thought that the addition of pores near the 
cortical surface may encourage ingrowth of meningeal tissue in a similar 
manner to that previously demonstrated with hollow fiber membranes, and 
thereby minimize growth down the implant shaft to the recording region, 
ultimately minimizing neuronal death or displacement.  Planar implants 
composed of a previously described shape memory polymer substrate were 
employed for this study (Ware et al., 2012).  Experimental implants had a set of 
9 pores in the shank region near the cortical surface, and control implants were 
solid.  The 4-shank (150 m x 35 m cross section; spike center-to-center 
450 m, 800 m long) polymer implants in the shape of intracortical multi-
electrode arrays were implanted in rat cortex for four weeks, and quantitative 
histological analysis was performed using markers for reactive astrocytes, 
neuron cell bodies, IgG to measure blood-brain barrier integrity and vimentin to 
identify meningeal tissue and proximal reactive astrocytes.  
3.2 Methods 
3.2.1 Subjects 
Six male Long Evans rats which made up the main cohort of the study 
were individually housed in a temperature- and humidity-controlled environment 
and were exposed to a 12:12 h light-to-dark cycle with free access to food and 
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water. IgG and neuron density data were obtained from an additional four rats 
which were implanted in the same manner as the main cohort.  
3.2.2 Implants 
Implants for this study consisted of planar polymer electrodes laser cut 
from 35 m thick sheets. Each implant consisted of four penetrating spikes 
attached to a common tab, which remained above the cortical surface.  Each 
animal received one nonporous implant and one porous implant with two arrays 
of laser-cut holes in each penetrating spike, as shown in Figure 3.1.Eacharray 
consists of nine 20μm holes with 20μm edge to edge spacing with each row 
offset at an angle of 60 degrees. This design facilitates future recording 
electrodes by leaving sufficient area to pattern electrode traces between holes. 
The implants were positioned such that each penetrating spike was fully 
embedded in the cortical tissue and the connecting tab was flush with the 
cortical surface after implantation. The implant substrate material is a thiol-ene 
based shape memory polymer which undergoes a hydration-mediated dynamic 
softening process following implantation, in order to yield an improved 
mechanical match with the surrounding cortical tissue and reduce long-term 
inflammation. Fabrication and characterization of this material are described in 
further detail in Ware 2012 and Chapter 4.Implants were UV sterilized prior to 
implantation.  
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Figure 3.1: Diagrams and images of porous implants. Control implants are 
dimensionally identical aside from the lack of pores. Thickness of all implants is 
35 m. 
(A) Detail drawing showing pore arrangement and location. All dimensions in 
μm. 
(B) Drawing showing overall size and shape of porous implant.  
(C) Detail photograph showing pores near base of shank 
(D) Photograph of entire implant 
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3.2.3 Surgical Procedures 
Surgical procedures are similar to those reported in section 2.2.3. Rats 
were anesthetized using ketamine, xylazine and acepromazine (targeted 
dosage 50, 20, 5 mg/kg respectively). A midline incision was made in the scalp 
and the connective tissue was dissected from the skull.  Two bone screws were 
implanted into the left side of the skull to secure the acrylic skull cap.  A 
3mm×5mm portion of the right parietal bone was removed using micro-
rongeurs, and the dura was removed. One 4-shank implant of each treatment 
was inserted using micro-forceps. The implants were positioned such that each 
penetrating spike was fully embedded in the cortical tissue and the connecting 
tab was flush with the cortical surface after implantation. All subjects received 
both implant types in order to minimize the effects of animal-to-animal 
variability, and rostral/caudal arrangement of the two implant types was 
alternated between animals in order to eliminate potential confounding effects 
of positioning in the brain tissue. Following implantation, the brain was covered 
by a layer of silicone elastomer (Kwik-Cast; World Precision Instruments, Inc., 
FL) which secured the implant handling tabs. A layer of acrylic was then added 
to seal the craniotomy and secure the structure to the bone screws. The initial 
incision was closed using absorbable sutures. All procedures were carried out 
in accordance with protocols approved by the University of Texas at Dallas and 
University of Oklahoma Institutional Animal Care and Use Committees. 
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3.2.4 Immunohistochemistry 
At 4 weeks post-implantation, subjects were euthanized and perfused. 
Subjects were administered 0.7mL of the same ketamine cocktail used for the 
surgical procedure, and then transcardially perfused with 100mL of phosphate 
buffered saline (PBS) followed by 100mL of 4% paraformaldehyde in PBS. 
Implants were removed from the brain upon removal of the skull cap following 
perfusion. The brain was removed and stored for 4h immersed in 4% 
paraformaldehyde for postfixation. Following postfixation, excess tissue 
surround the areas of interest was removed and the resulting tissue blocks 
were placed in 30% sucrose in PBS for cryoprotection for 72h. The brains were 
cut into 20 m thick horizontal sections which were collected onto slides. All 
tissue was batch stained to minimize differences due to processing. The main 
group of tissue sections were labeled with antibodies for GFAP to label reactive 
astrocytes, NeuN (FOX3) to visualize neuron cell bodies, and vimentin to 
indicate meningeal fibroblasts and reactive astrocytes (Jones and Tuszynski, 
2002; Nakajima and Kohsaka, 2001; Polikov et al., 2005). Antibodies specific to 
IBA1 labeling reactive microglia are frequently used in studies of this kind 
(Harris et al., 2011a; Kim et al., 2004; Polikov et al., 2005; Winslow and Tresco, 
2010) but preliminary studies using this marker and similar implants found no 
migroglial activity at four weeks. Microglial activity is known to prevail much 
earlier in the time course of the immune response and decrease substantially 
by four weeks post implantation (Kalman, 2003; Polikov et al., 2005). Thus, 
analysis of the microglial reaction in this experiment was eliminated in favor of 
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more informative markers. Every third section was placed in a separate batch 
and labeled with a fluorescent antibody specific to rat IgG, in order to assess 
blood-brain barrier integrity at the implant site (Hoshino et al., 1996; Potter et 
al., 2012; Skousen et al., 2011). Antibody concentrations are shown in Table 
3.1. Sections were also taken from similar locations in the unimplanted left 
hemisphere for each rat to serve as controls for image analysis. These were 
processed in the same batch as the experimental sections. Following three 
10min washes in PBS, sections were blocked in 3% normal goat serum for 30 
minutes. Sections were then incubated overnight in primary antibody solutions 
in PBS containing 3% normal donkey serum and 0.3% Triton X-100.  The 
following day, sections were incubated in conjugated secondary antibodies for 
2h and coverslipped using Vectashield with DAPI (Vector Laboratories). IgG 
labeled sections were incubated in the conjugated antibody solution overnight, 
then washed and coverslipped the following day. Images were taken using an 
Olympus BH-2 microscope with a 10x objective and an Olympus DP70 digital 
camera.  
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Primary Antibodies  Secondary Antibodies  
Abcam # Type Dilution Abcam # Type Dilution 
4674 Chicken anti-
GFAP 
500:1 96951 Anti-chicken 488 100:1 
104225 Rabbit anti-
FOX3 (NeuN) 
500:1 7087 Anti-rabbit 
TRITC 
100:1 
8069 Mouse anti-
vimentin 
250:1 150119 Anti-mouse 647 100:1 
7094 Anti-rat IgG 
TRITC 
100:1    
Table 3.1: Antibody types and concentrations 
 
3.2.5 Analysis 
Following acquisition, images were subjected to computerized analysis 
to quantify various aspects of the immune response. The primary techniques 
used were intensity profiling to determine the magnitude and distribution of 
GFAP, vimentin and IgG labeled cells and cell counting to measure neuron 
density.  
3.2.5.1 Intensity analysis 
An intensity profiling scheme was used to measure pixel brightness 
values as a function of distance from the edge of the implant track. Radial 
intensity profiling has been used previously for microwire implants (Markwardt 
et al., 2013) but this method is not optimal for the oblong tracks produced by the 
planar implants used in the current study. A profiling method was developed 
wherein the user selects the two end points of the track along the center of its 
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longest axis, and the program measures 50 evenly spaced intensity profiles 
perpendicular to this centerline in each direction. Images are converted to 
greyscale, then threshold-based analysis is used to select the dark area of the 
track void, which is excluded from the intensity profile analysis in order to 
control for variations in void size and shape, as well as better characterizing the 
device-tissue interface. This analysis scheme utilizing track void exclusion and 
integrated mean intensity profiling is based upon those used by other 
researchers in the assessment of neural interface immune reactions (Biran et 
al., 2005; Harris et al., 2011a; Winslow and Tresco, 2010). The selected track 
void area is overlaid with a black mask, and the track centerline is then selected 
manually. Each profile line consists of the first 200 m of pixels with a value >0 
(e.g. beyond the void area mask). The resulting 100 profiles are averaged 
together to yield a mean profile for each track, which is then separated into 
25 m bins for analysis. Intensity values shown represent mean pixel values for 
each 25 m bin. An example track with overlaid intensity profile lines is shown in 
Figure 3.2. To control for animal to animal variations in native expression levels 
of the markers of interest, intensity measurements were taken from the 
unimplanted contralateral hemisphere and the mean values for each rat were 
subtracted from the corresponding mean implant profiles. Background intensity 
profiles were taken from the same locations in the image frame as the 
experimental tracks in order to account for spatial nonuniformities in microscope 
illumination (Biran et al., 2005).  Quantification of meningeal tissue at the 
implant sites was performed by subtracting the GFAP labeled image from the 
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vimentin labeled image for that section, leaving only areas which are vim+ and 
GFAP-. Example images illustrating the subtraction analysis process are shown 
in Figure 3.3. For pixels in which the GFAP intensity value is greater than the 
same pixel in the vimentin image, the value in the resulting subtraction image is 
zero. Due to the differences in spatial distribution of this tissue, void area masks 
could not be used, and all distance metrics are relative to the implant centerline 
rather than the void edge. When analyzing vim+/GFAP+ proximal reactive 
astrocytes, void masks from GFAP labeled images were overlaid on the 
vimentin labeled images, and then the intensity profile was taken. Since the 
GFAP mask excludes all vim+/GFAP- meningeal tissue and any other areas 
within or near the void not expressing GFAP, this ensures that only intensity 
values of vim+/GFAP+ tissue are measured. This cell population has been 
previously distinguished from vim-/GFAP+ “distal” reactive astrocytes (Ridet et 
al., 1997). 
In order to further characterize the spatial distribution of the various 
immune response components, the collected intensity profiles were also 
grouped for analysis by section depth. Although tissue sections were collected 
and numbered in an ordered manner, due to the geometric characteristics of 
the cortex and occasional loss of some sections, it is not possible to reliably 
assign a specific depth value to each tissue section. However, it is still possible 
to group the data into more general depth categories and obtain some idea of 
the distribution of the cells of interest according to cortical depth. Brains were 
sectioned until no visible implant tracks were present, allowing the depth of the 
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electrode tip to be determined by locating the deepest section with a discernible 
track void. Using this point as a reference and knowing the length of the 
implants, it is possible to gain an approximation of the depth of the rest of the 
sections.  For analysis, tissue sections were grouped into three depth zones, 
with the superficial zone beginning at the cortical surface and the deepest zone 
ending at the deepest section containing a full-width implant track. The number 
of intervening sections for each implant between these two levels is then evenly 
divided into the three analysis zones, and intensity profiles within those zones 
are averaged to gain a mean intensity curve for each track for each zone.  
Sections located in the tapered area of the electrode tip were excluded from all 
analyses to avoid confounding effects of reduced implant cross section at that 
location. This leaves 650 m of implant shank which was analyzed, meaning 
each depth zone accounts for approximately 1/3 of that length.  
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Figure 3.2: Illustration of intensity profile scheme on a typical GFAP-labeled 
implant track. Gray region indicates track void, which is excluded from intensity 
analysis. Dashed line shows track centerline and solid lines represent intensity 
profiles. Number of profiles has been reduced for clarity; actual analysis uses 
50 profiles per side. 
 
 
Figure 3.3: Image subtraction process 
(A) Vimentin labeled image of representative control implant track. Dashed 
line indicates implant size and approximate location 
(B) GFAP labeled image of the same track 
(C) Resulting greyscale image following subtraction of (B) from (A) showing 
Vim+/GFAP- meningeal tissue 
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3.2.5.2 Cell counting 
ImageJ software (NIH) was used to perform threshold-based automated cell 
counting to assess neuronal density surrounding the implant tracks. Cell 
selection criteria were fine tuned for each subject using unimplanted 
contralateral tissue sections. A range of threshold values were used for each 
implant track in order to account for variations in brightness, and the largest cell 
count returned was entered. The area of the track void in the NeuN labeled 
image was measured via a similar thresholding process and subtracted from 
the area of the 200 m diameter region of interest to calculate the cell density. 
This ensures that the resulting cell density value is not influenced by the size of 
the track void, since the area value used in the cells/area density calculation 
represents the amount of cortical tissue within the counting radius and excludes 
the void area. For the implant type comparison, density values from varying 
depths were averaged to gain a single mean density value for each implant 
shaft for statistical analysis. Vimentin, GFAP and meningeal tissue data were 
collected from a total of 42 implant tracks (21 porous and 21 controls) and IgG 
and neuron density data were collected from a total of 71 tracks (37 porous and 
34 controls). 
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3.3 Results 
Distribution and general morphology of the four histological markers used 
may be seen in Figure 3.4. An example porous implant track is shown with 
labels for GFAP (A), vimentin (B), IgG (C), and NeuN (D).  
 
Figure 3.4: Example images of the same implant track for the four markers 
used in this study, showing relative size and distribution of cellular reactions. 
Dashed line indicates implant size and approximate location 
(A) GFAP showing reactive astrocytes 
(B) Vimentin showing meningeal fibroblasts and proximal reactive 
astrocytes 
(C) IgG indicating blood-brain barrier leakage 
(D) NeuN showing neuron cell bodies 
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3.3.1 Meningeal Cells 
Vimentin, an extracellular matrix protein produced by meningeal cells but 
not widely expressed in cortical tissue, was used as a marker to indicate 
meningeally derived tissue surrounding the implant sites. This tissue was 
distinguished from vimentin-expressing reactive astrocytes through the 
subtraction of GFAP expressing regions, since meningeal fibroblasts express 
vimentin but not GFAP. In cases where meningeal tissue was found, it was 
located immediately adjacent to the implant, within the envelope of 
encapsulating reactive astrocytes. Typical images of the two implant types from 
one subject are shown in Figure 3.5(A) porous and (B) non-porous. 
Meningeal fibroblast tissue is shown in red.  
3.3.1.1 Quantitative measures 
Intensity profile analysis of vim+/GFAP- meningeal tissue around each 
implant type revealed significantly less meningeal cellular activity surrounding 
porous implants than control implants. This reduction is statistically significant 
for the first four of the eight 25 m distance bins that were analyzed, from 0 to 
100 m from the implant track centerline (t-tests, n=42, p<0.05). Results are 
shown in Figure 3.5(C). The mean intensity curves also illustrate the localized 
nature of the meningeal cell activity, which disappears almost completely by 
75 m in the case of the porous implants. Control implants exhibit mean 
meningeal reactions that are greater in both intensity and extent than that of the 
porous implants.  
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Figure 3.5: Vim+/GFAP- Meningeal tissue results 
(A) Typical porous implant track near the cortical surface. Meningeal 
tissue is shown in red, vim+/GFAP+ proximal reactive astrocytes 
in yellow, and vim-/GFAP+ reactivity in green  
(B) Nonporous control track from the same tissue section 
(C) Intensity of Vim+/GFAP- tissue for both implant types as a 
function of distance from the track centerline. (n=42, *p<0.05, 
**p<0.01) 
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3.3.1.2 Meningeal activity by section depth 
The same meningeal tissue intensity data shown in Figure 3.5 were also 
analyzed according to depth down the electrode tracks in order to examine the 
effects of implant porosity on the progress of meningeal tissue growth down the 
electrode shaft. Collected tissue sections were separated into three depth 
zones, with zone 1 being the most superficial. Figure 3.6 shows mean intensity 
values for the first four distance bins of the intensity profiles at each of the three 
depths for both implant types. A clear trend of decreasing meningeal cell levels 
in deeper tissue is evident. In the case of the first distance bin, shown in Figure 
3.6(A), where the greatest amount of meningeal tissue is found, porous 
implants provide the greatest reduction in meningeal cell activity in the sections 
near the implant tip. This is consistent with the hypothesis that implant porosity 
inhibits the growth of meningeal tissue down the electrode shank. ANOVA 
comparison between the three depth zones for each radius bin and implant type 
revealed statistically significant reductions in meningeal tissue levels from 
shallower to deeper zones in three cases – the zone 3 activity was found to be 
significantly less than that of zone 1 for the 50 m and 75 m bins in the case of 
the porous implants, and zone 2 activity was found to be significantly less than 
zone 1 for the control implants in the 100 m bin (Figure 3.6D). No significant 
trends or differences between the two implant types were found in the outer four 
distance bins from 125-200 m (data not shown). 
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Figure 3.6: Meningeal tissue intensity results for the first four distance bins as a 
function of tissue depth (t-tests, n=42) (*p<0.05, **p<0.01) 
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3.3.2 Vim+/GFAP+ reactive astrocyte results 
3.3.2.1 Morphology 
Dense sheaths of vimentin and GFAP expressing reactive astrocytes 
were found surrounding both implant types extending tens to at most a few 
hundred microns into the surrounding tissue. These cells display a stellate 
morphology which is typical of reactive astrocytes in the CNS. Typical images of 
implant tracks showing vimentin labeling of proximal reactive astrocytes for 
porous and control implants from the same subject are shown in Figure 3.7 (A) 
and (B) respectively.  
3.3.2.2 Quantitative Vim+/GFAP+ results 
Intensity profile analysis of vim+/GFAP+ proximal reactive astrocytes 
revealed no statistically significant differences in the activity of this cell type 
between the two implant types when averaged across all section depths (t-
tests, n=42). Results are shown in Figure 3.7 (C).  
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Figure 3.7: Vim+/GFAP+ Reactive astrocyte results 
(A) Typical porous implant track showing vimentin expression. Dashed 
line indicates implant size and location 
(B) Control implant track from the same subject 
(C) Intensity of vimentin expression by vim+/GFAP+ cells as a function of 
distance from the implant track edge 
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3.3.2.3 Vim+/GFAP+ activity by depth 
Levels of vimentin expression by proximal reactive astrocytes were also 
examined according to tissue depth zone, in order to determine whether 
reductions in meningeal tissue encapsulation at greater depths would 
correspond to reductions in other aspects of the immune response. Results are 
shown in Figure 3.8. Vimentin levels were found to be significantly greater for 
control implants than porous implants in the deepest zone for the first radius 
bin, as seen in Figure 3.8(A) (t-test, n=42, p<0.05). Although a trend of 
decreasing activity is evident in bin 1 for the porous implants, the pronounced 
and consistent depth trends that were observed in the meningeal cells are not 
present in reactive astrocytes. This is to be expected since these Vim+/GFAP+ 
cells are native to the cortical tissue and do not have to migrate down the 
electrode shaft from the meningeal space to reach the deeper regions of the 
implant.  
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Figure 3.8: Vim+/GFAP+ reactive astrocyte intensity as a function of tissue 
depth zone for the first four distance bins. (t-test, n=42, *p<0.05) 
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3.3.3 GFAP results 
Fluorescent labeling with antibodies for glial fibrillary acidic protein 
(GFAP) was used to identify reactive astrocytes surrounding the implants, 
which make up an important component of the cortical immune response. This 
metric includes both proximal and distal reactive astrocytes. GFAP labeling 
revealed regions of reactive astrocyte activity surrounding each implant shank, 
forming a densely packed, multilayered capsule which is typical of a neural 
implant at 4 weeks post-implantation.  
 
3.3.3.1 Quantitative GFAP Measures 
GFAP labeled images were subjected to the same intensity profiling 
analysis that was used to assess vimentin results. No significant differences in 
GFAP expression were found between the two implant types (t-tests, n=42, 
p>0.05). Results are shown in Figure 3.9.  
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Figure 3.9: GFAP results 
(A) Typical porous implant track showing GFAP labeled reactive 
astrocytes 
(B) Control implant track from the same tissue section 
(C) GFAP intensity for each implant type as a function of distance from 
the implant surface 
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As no significant differences between the two implant types were found 
in vimentin-expressing astrocyte levels, it is to be expected that the same would 
be true of the overall GFAP+ response.  GFAP data were also examined as a 
function of section depth, but no significant trends or differences between the 
implant types were found (data not shown).  
3.3.4 Neuron results 
Neuron cell body counting via NeuN antibody labeling was performed to 
determine the effects of implant porosity on neuron density in the surrounding 
region. Neurons within a 100 m radius of the implant center were counted. The 
void area surrounding each implant was subtracted from the total area of 
interest in order to make the resulting neuron density metric independent of void 
size. No difference in mean void area was found between the two implant types 
(t-test, n=72, p=0.64). It was found that the mean neuronal density within this 
region of interest was approximately 20% greater for porous probes than 
controls. This difference was found to be statistically significant (t-test, n=71, p< 
0.01). Results are shown in Figure 3.10. The reduction of neuronal dieoff in the 
immediate vicinity of the implant is one of the primary goals of neural interface 
development, and the observed improvement in neuron viability around the 
porous implants is likely to correspond to an improvement in recording 
performance for future functional recording probes.  
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Figure 3.10: Neuron results 
(A) Typical porous implant track showing neuron cell bodies (NeuN). Dashed 
line indicates implant size and location, dashed circle indicates 100 m 
cell counting radius 
(B) Control implant track from the same tissue section 
(C) Surrounding neuron density for each implant type (**p<0.01) 
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3.3.5 IgG results 
Fluorescent antibody labeling of IgG was used to assess blood brain 
barrier integrity by measuring the presence of serum antibody. Every third 
tissue section was labeled using a conjugated antibody specific to rat IgG. 
Results were assessed using the same intensity profiling method that was 
employed for vimentin and GFAP labeled images.  
IgG labeled sections exhibited areas of elevated IgG surrounding the 
electrode tracks, extending tens to a few hundred microns into the surrounding 
tissue. IgG labeling was not restricted to a particular cell type or cellular 
morphology, but was instead largely diffuse and locally uniform within the 
tissue, which is consistent with the diffusion of serum antibodies into the tissue 
surrounding a neural implant. Example images are shown in Figure 3.11(A) 
and (B). 
3.3.5.1 Quantitative IgG results 
Intensity profiling analysis of IgG labeling around the two implant types 
revealed no significant differences between the two implant types (t-test, n=71, 
p>0.05). Results are shown in Figure 3.11(C). As with the astrocyte reaction, 
the degree of IgG reactivity in cortical tissue is thought to be generally 
proportional to the level of mechanical stresses and trauma present in the 
tissue. Since the external dimensions, insertion method, and material of the 
porous and control implants are identical, this result is in line with expectations. 
IgG reactivity data were also examined according to section depth zone in the 
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same manner as above, and no significant trends or differences were found 
(data not shown).  
 
Figure 3.11: IgG results 
(A) Typical porous implant track showing IgG reactivity, indicating BBB 
permeability 
(B) Control implant track from the same tissue section 
(C) IgG intensity for each implant type as a function of distance from the 
implant surface 
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3.4 Discussion 
The results of this study demonstrate that the addition of pores to a planar 
probe near the cortical surface has a significant effect on several aspects of the 
brain’s immune response at 4 weeks post implantation. Significant reductions in 
vimentin-labeled cellular encapsulation activity and neuron dieoff were found 
compared to nonporous control implants. Examination of vim+/GFAP- 
meningeal cell activity according to section depth zone revealed that this tissue 
is most prevalent nearest the cortical surface, and decreases with increasing 
depth down the electrode shaft.  Measurements of IgG levels and reactive 
astrocyte activity were made, but no significant differences were found between 
the implant types.  
Encapsulation of penetrating neural electrodes by GFAP-expressing 
reactive astrocytes constitutes a significant portion of the cortical immune 
response, and a reduction in reactive astrocyte activity is frequently found in 
conjunction with reductions in neuron dieoff, such as were seen in the current 
study (Biran et al., 2005; Polikov et al., 2005; Thelin et al., 2011). A significant 
reduction in vim+/GFAP+ astrocytes for the porous implants was found for the 
deepest depth zone in the closest radius bin (Figure 3.8A), which could 
potentially be an indication of an interaction between the meningeal and 
astrocyte portions of the response. No significant differences were found 
between the two implants in the mean vim+/GFAP+ or total GFAP+ reactions, 
though, so any interactive phenomena between the two portions are subtle.  
Although significant reductions in GFAP and vimentin expressing reactive 
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astrocytes were not observed, the improvement in local neuron density and 
reduction in vim+/GFAP- meningeal tissue levels illustrate that the addition of 
pores to these implants near the cortical surface has a significant effect on the 
immune response. It seems likely, then, that disparate mechanisms may be 
responsible for determining the magnitude of the astrocyte- and meningeal cell-
mediated portions of the immune reaction. Astrocyte responses have been 
shown to be affected by changes in implant size, shape, composition, 
implantation method, and implantation location (Biran et al., 2005; Harris et al., 
2011a; Kim et al., 2004; Polikov et al., 2005; Rennaker et al., 2005b; Thelin et 
al., 2011; Turner et al., 1999). Generally speaking, these factors relate to the 
degree of mechanical trauma inflicted upon the tissue surrounding the implant. 
Higher insertion speeds and smaller implants reduce mechanical strains on the 
tissue, and produce a reduction in GFAP levels (Rennaker et al., 2005b; 
Rousche and Normann, 1992; Welkenhuysen et al., 2011). Free-floating 
implants, when compared to those anchored to the skull, reduce chronic 
micromotion between the implant and the surrounding tissue, reducing chronic 
mechanical stresses and reducing GFAP expression (Biran et al., 2005; Kim et 
al., 2004; Thelin et al., 2011). All of these factors were unchanged between the 
two implant types in this experiment. Although the porous regions may have a 
small effect on the bulk mechanical stiffness of the implants, none of the factors 
which have been previously implicated in governing the astrocyte reaction are 
related to the implant porosity being evaluated in this study. Similarly, no 
significant differences were found in IgG labeling between the two implant 
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types, but like GFAP, cortical IgG levels have been shown to be largely related 
to physical trauma (Hoshino et al., 1996). Since there are no substantial 
differences in the mechanical behavior of the two implant types used in this 
study, the lack of significant differences in IgG levels is not surprising. As no 
differences were observed in the astrocyte-mediated portion of the immune 
response, but significant differences in meningeal tissue ingrowth were shown, 
the observed reduction in neuron dieoff appears to be at least partially linked to 
the activity of meningeally derived, vimentin expressing cells. 
Ingrowth of vimentin labeled meningeal cells into a porous cortical implant 
structure has been shown previously, and served as one of the primary 
motivations for the current study (Kim et al., 2004). Although the hollow fiber 
membrane implant employed differs significantly from that used in the current 
study, the vim+/GFAP- results show that the porous structures in planar SMP 
implants reduced growth of meningeal tissue around the implant shafts at 4 
weeks. Although fibrous encapsulation by GFAP expressing reactive astrocytes 
receives much attention as a failure mode for penetrating neural interfaces, the 
results of this study suggest that encapsulation by meningeally derived cells 
may be another important factor to consider when attempting to improve device 
performance. Morphologically, the meningeal tissue structures observed in the 
current study resemble normal meningeal tissue found at the edges of the 
tissue sections. Although this differs in structure from the glia limitans and 
fibrous capsule formed by reactive astrocytes, the addition of another fibrous 
tissue layer between the electrode recording sites and the surrounding neurons 
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can scarcely improve recording performance.   Although functional recording 
devices were not used in the current study and the specific effects of 
vimentin+/GFAP- tissue encapsulation on penetrating neural electrode 
performance remain largely uninvestigated, one expects that the effects of 
encapsulation by meningeally derived cells on implant performance would be 
substantially similar to that of astrocytic encapsulation. Namely, a fibrous tissue 
layer is formed around the electrode, electrically insulating the recording sites 
from the surrounding neurons and increasing the physical separation between 
the probe and the cells of interest. Although the meningeal component of the 
encapsulation response and the detrimental effects thereof could be smaller in 
magnitude than the astrocytic reaction, it is also significantly less well 
understood. The results of this experiment demonstrate that at least one 
physical characteristic of a neural implant can significantly influence this portion 
of the immune response, and many more potentially beneficial techniques are 
likely as yet undiscovered. The development of a reliable chronic cortical neural 
interface will depend upon a thorough understanding not only of the microglial 
and astrocytic portions of the immune response, but the meningeal components 
as well, and further work is required in order to fully understand this component 
of the cortical reaction to a neural implant.  
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3.5 Conclusion 
Quantification of the cortical immune response to porous-shank and 
nonporous control neural implants revealed that the addition of pores to the 
implant shank near the level of the cortical surface reduces the migration of 
vimentin+/GFAP- meningeal cells down the implant shaft at four weeks. Porous 
implants also improved local neuronal density compared to controls. These 
results suggest that this novel neural implant design feature may prove to be a 
beneficial addition to future neural interface designs.  These results also 
indicate that the physical characteristics of a neural electrode can have 
significant effects on a portion of the encapsulation response which is separate 
from the glial cell mediated reaction, and other factors influencing this 
meningeal response to neural implants remain poorly understood. The 
development of clinically viable cortical neural interfaces necessitates a full 
understanding of the implant’s interaction with all dimensions of the cortical 
immune response, and more investigation of the meningeal component is 
warranted.  
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4 Dynamically Softening Polymer Neural Implant Substrate 
 
4.1 Introduction 
4.1.1 Flexible neural interfaces 
Recently, a number of groups have investigated neural implants 
composed of softer, more flexible materials than conventional silicon arrays, in 
order to reduce the mechanical mismatch between the implant and the 
surrounding brain tissue and reduce chronic inflammation. In vivo and in vitro 
studies have found that higher tissue strain rates and stiffer implant substrates 
elicit increased astrocyte reactivity (Cullen et al., 2007). These include implants 
composed of polyimide (Cheung, 2007; Fomani and Mansour, 2011; Mercanzini 
et al., 2008; Rousche et al., 2001), poly(vinyl acetate) nanocomposites (Harris 
et al., 2011a), benzocyclobutene (Lee et al., 2005), parylene (Kim et al., 2013; 
Takeuchi et al., 2005; Wester et al., 2009) and silicone (PMDS) (Kozai and 
Kipke, 2009; McClain et al., 2011). These implants have shown promise at 
reducing the chronic immune response but still suffer from serious design 
compromises. All of these implants must still be made sufficiently stiff to allow 
insertion into the brain tissue, or use other methods, such as an insertion 
shuttle (Kozai and Kipke, 2009) or a thick coating of saccharose (Hassler et al., 
2011) to aid insertion, which give rise to other issues. For softer materials, the 
implant must be made thicker and wider in cross section to facilitate insertion, 
increasing its footprint in the tissue, insertion trauma and chronic inflammation. 
Even when flexible materials such as polyimide or parylene-c are employed, the 
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difference between the moduli of the implant and the surrounding tissue is still 5 
or 6 orders of magnitude  (Rousche et al., 2001; Ware et al., 2012).  Harris 
(2011) describes a polymer nanocomposite neural implant substrate which 
undergoes a dramatic decrease in tensile storage modulus following 
introduction to physiological conditions, but this is accompanied by aqueous 
swelling of 60-75%, leading to additional forces on the surrounding tissue.   
4.1.2 Dynamically softening substrate 
Shape memory polymers offer the ability to eliminate this compromise by 
using a single material which changes its mechanical properties following 
insertion in the cortical tissue. Via careful manipulation of the material’s 
chemistry, the glass transition temperature can be tuned to just above 
physiological temperature. The addition of hydrophilic polymers to the 
formulation introduces tunable hydration sensitivity as well. Thus, the implant 
material is in its stiff state for insertion, and then transitions to the compliant 
state shortly following insertion due to plasticization by a small amount of fluid 
uptake. The polymer used in this study has a comparable stiffness to current 
flexible probes for insertion (Young’s modulus of ~3GPa), and then undergoes a 
dramatic decrease in its stiffness over a period of a few days following 
implantation to about 10MPa (Ware et al., 2012).  Approximate modulus ranges 
of the SMP system and other neural interface substrates are shown in Figure 
4.1. Synthesis and characterization of the dynamically softening substrate used 
in this study is reported in Ware 2012. The experimental implants used in this 
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experiment consisted of only the SMP substrate without any recording 
functionality.  
 
 
Figure 4.1: Schematic showing modulus ranges of other neural interface 
materials and the SMP system 
 
The aim of this study is to measure the effect of the dynamic softening 
property of the SMP system on the brain’s immune response. To determine 
whether this system offers benefits over current neural interface substrates, 
implants made with our SMP substrate are compared to probes of identical 
dimensions composed of parylene-c. Parylene-c (poly[dichloro-p-xylylene]) is 
an FDA Class VI polymer coating used in medical devices in many areas of the 
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body, and it has been used by several researchers as a coating or flexible 
substrate for neural interfaces (Hassler et al., 2011; Hassler et al., 2010; Hsu et 
al., 2009; Schmidt et al., 1988; Takeuchi et al., 2005; Wester et al., 2009). 
Evaluation of parylene-c coatings on neural implants has found the immune 
response to be similar to that of uncoated silicon implants (Winslow et al., 
2010). Parylene-c provides a good control against which to evaluate the 
benefits of the SMP substrate’s softening capability, as its stiffness prior to 
implantation is comparable (~3GPa), and parylene-c undergoes no change in 
modulus over the indwelling period (Hassler et al., 2010). Previous evaluation of 
the SMP material has shown that its modulus is reduced to ~10MPa after 1 
week in physiological conditions and stabilizes thereafter (Ware et al., 2012). 
Implants used in this study are a planar design consisting of four 150 m wide 
penetrating spikes 35 m thick joined by a common tab. Six rats were each 
implanted with one 4-shank SMP implant and one dimensionally identical 
parylene-c control implant for a period of four weeks. Brains were sectioned and 
subjected to quantitative immunohistochemistry analysis to quantify the chronic 
immune response to each implant type and measure the effect of the SMP 
substrate’s dynamic softening capability.  
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4.2 Methods 
4.2.1 Subjects 
Six female Sprague-Dawley rats were individually housed in a 
temperature- and humidity-controlled environment and were exposed to a 12:12 
h light-to-dark cycle with free access to food and water. 
4.2.2 Implants 
Development, synthesis and characterization of the SMP substrate are 
described in detail in Ware et al. 2012. Briefly, the system consists of 31mol% 
tricyclodecanedimethanoldiacrylate (TCMDA) and 1,3,5-triallyl-1,3,5-triazine-
2,4,6(1H,3H,5H)-trione (TATATO) monomers with 0.1%wt 2,2-dimethoxy-2-
phenyl acetophenone (DMPA) and Tris[2-(3-mercaptopropionyloxy)ethyl] 
isocyanurate (TMICN). Polymerization was performed using 365nm UV. To 
fabricate the parylene-c control implants, 35 m of parylene-c was deposited in 
five successive depositions using a Labcoater 2 (SCS Systems). A frequency 
tripled Nd:YAG laser connected to a Fab workstation (Newport) was used to 
cut device profiles from the surrounding polymer sheet. The implants used in 
the current study consisted of only the SMP or parylene-c substrate without any 
recording functionality. Implant shape and dimensions are shown in Figure 4.2. 
Implant thickness is 35 m. Dynamic mechanical analysis characterization of the 
SMP material was performed using a Mettler Toledo DMA 861e/SDTA. 
Samples consisted of 1mm diameter, 3mm thick cylinders placed under shear 
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deformation at 1Hz following incubation in physiological conditions(Ware et al., 
2012).  
 
Figure 4.2: Implant dimensions. Implant thickness is 35 m. 
(A) Drawing of implant. All dimensions in m. 
(B) Photograph of implant spikes 
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4.2.3 Surgical Procedures 
Rats were anesthetized using ketamine, xylazine and acepromazine 
(targeted dosage 50, 20, 5 mg/kg respectively). A midline incision was made in 
the scalp and the connective tissue was dissected from the skull.  Two bone 
screws were implanted in the left parietal bone to secure the acrylic skull cap.  
A 3mm × 5mm portion of the right parietal bone was removed using micro-
rongeurs. A 28-ga needle was used to incise and remove the dura over the 
implant site before insertion of the probes. One 4-shank implant of each type 
was inserted using micro-forceps. The implants were positioned such that each 
penetrating spike was fully embedded in the cortical tissue and the connecting 
tab was flush with the cortical surface after implantation. All animals received 
one SMP and one parylene control implant in order to minimize the effects of 
animal-to-animal variability, and the rostral/caudal arrangement of the two 
implant types was alternated between animals in order to eliminate potential 
confounding effects of positioning in the brain tissue. Following implantation, the 
brain was covered by a layer of silicone elastomer (Kwik-Cast; World Precision 
Instruments, Inc., FL) and a layer of acrylic was added to seal the craniotomy 
and secure the structure to the bone screws. The initial incision was then closed 
using absorbable sutures. All procedures were carried out in accordance with 
protocols approved by the University of Texas at Dallas and University of 
Oklahoma Institutional Animal Care and Use Committees. 
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4.2.4 Immunohistochemistry 
 At 4 weeks post-implantation, subjects were euthanized and 
perfused. Subjects were administered 0.7mL of the same ketamine cocktail 
used for the surgical procedure, and then transcardially perfused with 100mL of 
phosphate buffered saline (PBS) followed by 100mL of 4% paraformaldehyde in 
PBS. Implants were removed from the brain upon removal of the skull cap 
following perfusion. The brain was removed and stored for 4h immersed in 4% 
paraformaldehyde for postfixation. Following postfixation, excess tissue 
surround the areas of interest was removed and the resulting tissue blocks 
were placed in 30% sucrose in PBS for cryoprotection for 72h. The brains were 
cut into 20 m thick horizontal sections which were collected onto slides. All 
tissue was stained in a single batch to minimize processing variability. The main 
group of tissue sections was labeled with antibodies for GFAP to label reactive 
astrocytes, NeuN (FOX3) to visualize neuron cell bodies, and vimentin to 
indicate meningeal fibroblasts and reactive astrocytes (Jones and Tuszynski, 
2002; Nakajima and Kohsaka, 2001; Polikov et al., 2005). Antibodies specific to 
IBA1 labeling reactive microglia are frequently used in neural interface 
immunohistochemistry studies (Harris et al., 2011a; Kim et al., 2004; Polikov et 
al., 2005; Winslow and Tresco, 2010) but preliminary studies using this marker 
and similar implants found no migroglial activity at 4 weeks. Microglial activity is 
known to prevail much earlier in the time course of the immune response and 
decrease substantially by 4 weeks post implantation (Kalman, 2003; Polikov et 
al., 2005). Thus, analysis of the microglial reaction in this experiment was 
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eliminated in favor of more informative markers. Every third section was placed 
in a separate batch and labeled with a fluorescent antibody specific to rat IgG, 
in order to assess blood-brain barrier integrity at the implant site (Hoshino et al., 
1996; Potter et al., 2012; Skousen et al., 2011). Antibody concentrations are 
shown in Table 4.1. Sections were also taken from similar locations in the 
unimplanted left hemisphere for each rat to serve as controls for image 
analysis. These were processed in the same batch as the experimental 
sections. Following three 10min washes in PBS, sections were blocked in 3% 
normal goat serum for 30 minutes. Sections were then incubated overnight in 
primary antibody solutions in PBS containing 3% normal donkey serum and 
0.3% Triton X-100.  The following day, sections were incubated in conjugated 
secondary antibodies for 2h and coverslipped using Vectashield with DAPI 
(Vector Laboratories). IgG labeled sections were incubated in the conjugated 
antibody solution overnight, then washed and coverslipped the following day. 
Images were taken using an Olympus BH-2 microscope with a 10x objective 
and an Olympus DP70 digital camera.  
 
 
 
 
 
 
98 
 
Primary Antibodies  Secondary Antibodies  
Abcam # Type Dilution Abcam # Type Dilution 
4674 Chicken anti-
GFAP 
500:1 96951 Anti-chicken 488 100:1 
104225 Rabbit anti-
FOX3 (NeuN) 
500:1 7087 Anti-rabbit 
TRITC 
100:1 
8069 Mouse anti-
vimentin 
250:1 150119 Anti-mouse 647 100:1 
7094 Anti-rat IgG 
TRITC 
100:1    
Table 4.1: Antibody types and concentrations 
4.2.5 Analysis 
Following acquisition, images were subjected to computerized analysis 
to quantify various aspects of the immune response. The primary techniques 
used were intensity profiling to determine the magnitude and distribution of 
GFAP, vimentin and IgG labeled cells and cell counting to measure neuron 
density.  
4.2.4.1 Intensity Analysis 
An intensity profiling scheme was used to measure pixel brightness 
values as a function of distance from the edge of the implant track. Radial 
intensity profiling has been used previously for microwire implants (Markwardt 
et al., 2013) but this method is not optimal for the oblong tracks produced by the 
planar implants used in the current study. A profiling method was developed 
wherein the user selects the two end points of the track along the center of its 
longest axis, and the program measures 50 evenly spaced intensity profiles 
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perpendicular to this centerline in each direction. Images are converted to 
greyscale, then threshold-based analysis is used to select the dark area of the 
track void, which is excluded from the intensity profile analysis in order to 
control for variations in void size and shape, as well as better characterizing the 
device-tissue interface. This analysis scheme utilizing track void exclusion and 
integrated mean intensity profiling is based upon those used by other 
researchers in the assessment of neural interface immune reactions (Biran et 
al., 2005; Harris et al., 2011a; Winslow and Tresco, 2010). The selected track 
void area is overlaid with a black mask, and the track centerline is then selected 
manually. Each profile line consists of the first 200 m of pixels with a value >0 
(e.g. beyond the void area mask). The resulting 100 profiles are averaged 
together to yield a mean profile for each track, which is then separated into 
25 m bins for analysis. Intensity values shown represent mean pixel values for 
each 25 m bin. An example track with overlaid intensity profile lines is shown in 
Figure 4.3.  
100 
 
 
Figure 4.3: Illustration of intensity profile scheme on a typical GFAP-labeled 
implant track. Gray region indicates track void, which is excluded from intensity 
analysis. Dashed line shows track centerline and solid lines represent intensity 
profiles. Number of profiles has been reduced for clarity; actual analysis uses 
50 profiles per side. 
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To control for animal to animal variations in native expression levels of 
the markers of interest, intensity measurements were taken from the 
unimplanted contralateral hemisphere and the mean values for each rat were 
subtracted from the corresponding mean implant profiles.  Background intensity 
profiles were taken from the same locations in the image frame as the 
experimental tracks in order to account for spatial nonuniformities in microscope 
illumination (Biran et al., 2005; Kim et al., 2004).  Quantification of vim+/GFAP- 
meningeal tissue at the implant sites was performed by subtracting the GFAP 
labeled image from the vimentin labeled image for that section, leaving only 
areas which are vim+ and GFAP-. Example images illustrating the subtraction 
analysis process are shown in Figure 4.4. For pixels in which the GFAP 
intensity value is greater than the same pixel in the vimentin image, the value in 
the resulting subtraction image is zero. Due to the differences in spatial 
distribution of this tissue, void area masks could not be used, and all distance 
metrics are relative to the implant centerline rather than the void edge. When 
analyzing vim+/GFAP+ proximal reactive astrocytes, void masks from GFAP 
labeled images were overlaid on the vimentin labeled images, and then the 
intensity profile was taken. Since the GFAP mask excludes all vim+/GFAP- 
meningeal tissue and any other areas within or near the void not expressing 
GFAP, this ensures that only intensity values of vim+/GFAP+ tissue are 
measured. This vim+/GFAP+ proximal reactive astrocyte cell population has 
been previously distinguished from vim-/GFAP+ “distal” reactive astrocytes 
(Ridet et al., 1997). 
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Figure 4.4: Image subtraction process. Dashed line indicates implant size and 
approximate location 
(A) Vimentin labeled image of representative control implant track.  
(B) GFAP labeled image of the same track 
(C) Resulting greyscale image following subtraction of (B) from (A) showing 
Vim+/GFAP- meningeal tissue 
 
 
 
 
4.2.4.2 Cell counting 
ImageJ software (NIH) was used to perform threshold-based automated 
cell counting to assess neuronal density surrounding the implant tracks. Cell 
selection criteria were fine tuned for each subject using unimplanted 
contralateral tissue sections. A range of threshold values were used for each 
implant track in order to account for variations in brightness, and the largest cell 
count returned was entered. The area of the track void in the NeuN labeled 
image was measured via a similar thresholding process and subtracted from 
the area of the 200 m diameter region of interest to calculate the cell density. 
This ensures that the resulting cell density value is not influenced by the size of 
the track void, since the area value used in the cells/area density calculation 
represents the amount of cortical tissue within the counting radius and excludes 
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the void area. For the implant type comparison, density values from varying 
depths were averaged to gain a single mean density value for each implant 
shaft for statistical analysis. Analyzable data were collected from a total of 41 
implant tracks (22 SMP and 19 parylene). 
 
4.3 Results 
Morphology and general distribution of the four histological markers used 
in this study may be seen in Figure 4.5. An example control implant track is 
shown with labels for GFAP (A), vimentin (B), NeuN (C) and IgG (D).  
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Figure 4.5: Example images. Dashed line indicates implant width and 
approximate location. 
(A) Example control implant track showing GFAP labeling of reactive 
astrocytes.  
(B) Vimentin labeling of the same track showing meningeal tissue and 
proximal reactive astrocytes 
(C) NeuN labeling showing neuron cell bodies 
(D) IgG reactivity of the same track in an adjacent tissue section 
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4.3.1 GFAP 
GFAP expressing reactive astrocytes play a central role in the brain’s 
immune reaction, and the reduction of this portion of the immune response is 
one of the primary goals of current neural interface development. Areas of 
GFAP+ cells were found surrounding all implant tracks, typically forming a 
dense capsule immediately surrounding the implant. Individual GFAP+ cells 
were found extending tens to a few hundred microns into the surrounding 
tissue. These cells display a stellate morphology which is typical of reactive 
astrocytes in the CNS. Example GFAP labeled images are shown in Figure 
4.6(A) and (B). 
 
4.3.1.1 Quantitative GFAP measures 
Intensity profile analysis found significantly reduced levels of mean 
GFAP+ intensity for the SMP implants for the first two distance bins from 0-
50 m from the track void edge compared to controls (t-tests, n=41, p<0.05). 
Differences in GFAP expression between the two implant types from 75 m 
outwards were not significant. Results are shown in Figure 4.6(C).  
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Figure 4.6: GFAP results 
(A) Typical SMP implant track showing GFAP labeled reactive astrocytes 
(B) Control implant track from the same tissue section 
(C) GFAP intensity for each implant type as a function of distance from the 
track margin +/-95%CI (***p<.001, *p<.05) 
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4.3.2 Vim+/GFAP+ Results 
A subpopulation of reactive astrocytes in the CNS expresses vimentin in 
addition to GFAP. These have been termed proximal reactive astrocytes, since 
they tend to be restricted to the more immediate vicinity of the implant. 
Meningeal tissue, which expresses vimentin but not GFAP, is excluded from 
this portion of the analysis. Vim+/GFAP+ reactive astrocytes were found 
immediately surrounding implant tracks, frequently forming a dense capsule of 
interdigitating cellular processes. Typical vimentin labeled images of SMP and 
parylene-c implants are shown in Figure 4.7(A) and (B) respectively.  
 
4.3.2.1 Quantitative Vim+/GFAP+ Results 
As is the case with GFAP labeled astrocytes, analysis of vimentin 
expression showed significantly reduced intensity in the first 50 m for SMP 
implants compared to controls (t-tests, n=41, p<0.05). Differences in intensity 
from 75-200 m were not significant. Results are shown in Figure 4.7(C). 
Comparison of the GFAP intensity curve shown in Figure 4.6(C) with the 
vimentin intensity curve illustrates the more localized nature of the vimentin 
expressing astrocyte reaction, which falls off in intensity at greater distance 
more quickly than the mean GFAP intensity curves.  
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Figure 4.7: Vim+/GFAP+ results 
(A) Typical SMP implant track showing vim+/GFAP+ proximal reactive 
astrocytes 
(B) Control implant track from the same tissue section 
(C) Vimentin intensity for each implant type as a function of distance from 
the track margin +/-95%CI (***p<.001, *p<.05). 
109 
 
4.3.3 Vim+/GFAP- Meningeal Tissue Results 
Meningeally derived fibroblasts have been shown to migrate into the 
cortex down the length of penetrating neural implants and participate in the 
immune response alongside native cell populations. These cells are identified 
by the subtraction of the GFAP+ labeled image from the vimentin+ labeled 
image of the same section, leaving areas which express vimentin but not 
GFAP. These areas, when present, tend to form the innermost layer adjacent to 
the implant. Example images are shown in Figure 4.8(A) and (B).  
 
4.3.3.1 Quantitative meningeal tissue results 
Intensity profile analysis of Vim+/GFAP- regions revealed no significant 
differences in meningeal tissue levels between the two implant types (t-tests, 
n=41, p>0.05). Results are shown in Figure 4.8(C). Due to the morphology and 
distribution of the meningeal tissue and the frequent lack of a clearly defined 
void, distance bin measurements for this marker are relative to the track 
centerline rather than the void edge as with all other metrics.  
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Figure 4.8: Vim+/GFAP- Meningeal tissue results 
(A) Representative SMP implant track showing Vim+/GFAP- meningeal 
tissue in red, Vim+/GFAP+ proximal reactive astrocytes in yellow, and 
Vim-/GFAP+ astrocytes in green. Dashed line denotes implant location. 
(B) Control implant track from the same subject  
(C) Vim+/GFAP- meningeal tissue intensity for both implant types as a 
function of distance from the track centerline +/-95%CI 
111 
 
4.3.4 IgG  
A subset of tissue sections was analyzed via fluorescent labeling of IgG, 
a common serum antibody type. Elevated levels of IgG in cortical tissue, which 
is normally devoid of serum immunoglobulins, are indicative of blood brain 
barrier compromise due to mechanical trauma (Hoshino et al., 1996; Potter et 
al., 2012). IgG labeled sections showed regions of elevated IgG surrounding the 
implant tracks. IgG labeling was not restricted to a particular cell type, but 
instead formed diffuse bright regions around each track extending into the 
surrounding tissue. Example images are shown in Figure 4.9(A) and (B).  
 
4.3.4.1 Quantitative IgG results 
Intensity profile analysis of IgG labeling revealed no significant 
differences between the two implant types (t-tests, n=41, p>0.05). Results are 
shown in Figure 4.9(C).  
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Figure 4.9: IgG results 
(A) Typical SMP implant track showing IgG reactivity. Dashed line denotes 
implant location. 
(B) Control implant track from the same subject 
(C) IgG intensity as a function of distance from the implant track margin +/-
95%CI 
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4.3.5 Neuron results 
Automated cell counting of NeuN labeled cell bodies was used to 
quantify levels of neuron dieoff surrounding the implants within a 100 m radius. 
No significant difference in mean neuron density was found between the two 
implant types. Results are shown in Figure 4.10. Mean void areas were also 
found to be similar between the two implant types (t-test, n=41, p=0.36). 
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Figure 4.10: Neuron results 
(A) Typical SMP implant track showing NeuN labeling of neuron cell bodies. 
Dashed line indicates implant location, circle shows 100 m cell counting 
radius 
(B) Control implant track from the same subject 
(C) Mean neuron densities for both implant types +/-95%CI. 
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4.4 Discussion 
The development of a reliable future chronic neural interface requires a 
substantial increase in both the reliability and longevity of neural signals over 
those obtained with current devices. One of the primary strategies for improving 
recording performance is reduction of the brain’s foreign body response to the 
implant, and the type of material used for the implant’s substrate has received 
much attention as a potential way to mitigate the undesirable aspects of the 
immune reaction. Flexible implants which provide a closer mechanical match to 
the surrounding brain tissue and thus reduce chronic irritation have shown 
promise at reducing the glial scarring response, and the SMP system has 
mechanical properties and capabilities which should make it a prime candidate 
for neural interface substrates.  
Previous work has gathered significant evidence for the hypothesis that the 
reactive astrocyte response to a neural interface is related to trauma and 
mechanical stresses in the tissue surrounding the implant (Biran et al., 2005; 
Harris et al., 2011a; Harris et al., 2011b; Hassler et al., 2011; Kim et al., 2004; 
Rennaker et al., 2005b; Rousche et al., 2001; Stice et al., 2007; Thelin et al., 
2011). These stresses can be related to the method of implant insertion, type of 
implant fixation, or the mechanical properties of the implant itself. The results of 
this study lend further support to this hypothesis. Dynamically softening shape 
memory polymer neural implants, when compared to dimensionally identical 
parylene-c implants, were found to elicit a reduced reactive astrocyte reaction at 
4 weeks. Previous studies have shown that reactive astrocyte activity may be 
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reduced via a reduction in implant stiffness and thus a reduction in chronic 
mechanical stresses in the surrounding tissue, and the results of the current 
study corroborate those findings (Cheung, 2007; Harris et al., 2011a; 
Mercanzini et al., 2008).  Encapsulation of neural electrodes by reactive 
astrocytes is thought to be one of the main recording device failure modes, and 
the glial reaction has been associated with numerous phenomena that are 
detrimental to neural tissue viability and recording device performance. 
Although functional recording devices were not employed in the current study, 
the observed reduction in reactive astrocyte activity as a result of the implant’s 
dynamic softening capability is likely to correspond to an improvement in 
recording performance, according to the current understanding of reactive 
gliosis and neural electrode function.  
Recent work has begun to focus more on the role of meningeally derived 
tissues in the immune response. Meningeally derived fibroblasts have been 
shown to migrate down the shaft of a penetrating neural implant and contribute 
to the immune reaction (Kim et al., 2004; Woolley et al., 2013). These cells may 
be differentiated from native glial populations by the fact that they express 
vimentin but not GFAP. Image subtraction was used to identify meningeal 
tissue surrounding the implants in the current study, and no significant 
differences in the amount of this tissue were found between the two implant 
types. A thorough account of the factors which influence the meningeal portion 
of the immune response to a neural electrode has yet to be assembled, but the 
results of this study suggest that the meningeal response is independent of the 
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modulus of the implant. Other work, including the results outlined in Chapter 3, 
has shown that the degree of infiltration of meningeal cells is in part dependent 
upon the spatial relationship between the implant and the meningeal space, as 
well as implant porosity, and since SMP and control implants in the current 
study were identical in terms of size, shape, and positioning in the cortex, a 
significant difference in meningeal tissue levels between the two implant types 
is not expected.  
Examination of IgG levels surrounding also revealed no significant 
differences between the two implant types. Although significant levels of IgG in 
cortical tissue are known to be a result of mechanical trauma and resulting 
blood-brain barrier damage, IgG measurement to evaluate neural interfaces is a 
relatively novel technique (Cortez et al., 1989; Hoshino et al., 1996). Thus, it 
cannot be easily determined whether the bulk of the IgG reaction that was 
observed is a result of initial insertion trauma or chronic mechanical stresses 
without further investigation at multiple timepoints following implantation. It 
seems likely that a significant portion of the observed IgG signal would be due 
to insertion trauma, since the stresses on the tissue during probe insertion are 
much higher than the chronic stresses generated by small perturbations of the 
implant. Since the probe dimensions and insertion method did not vary between 
the two implant types, the mechanical stresses undergone by the tissue during 
implant insertion should not vary significantly between the implant types. Any 
differences in IgG release into the tissue which are a result of chronic stress 
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reduction from dynamic implant softening may well be masked by the large IgG 
signal produced during implantation.  
Examination of neuron density in the 100 m maximum recording radius 
around the implants revealed no significant differences between the two implant 
types. One study found that a nanocomposite based softening implant improved 
neuron viability (Harris et al., 2011a), but the softening implants were compared 
to tungsten microwires rather than the parylene-c controls used in the current 
study, giving a difference in modulus two orders of magnitude greater than that 
used in the current study (400GPa and 12MPa for tungsten and nanocomposite 
versus 3GPa and 10MPa for parylene-c and softened SMP, respectively). Thus 
it is possible that the modulus difference between the SMP and control implants 
in the current study was not large enough to elicit a significant difference in 
neuron dieoff between the two implant types.  
 Although the current study did not find improvements in neuron density, 
the SMP system neatly addresses one of the primary shortcomings of very 
compliant implants in that it is sufficiently stiff to facilitate insertion without any 
additional material or devices. Additionally, it offers potentially improved 
performance due to the reduction of the glial scarring response when compared 
to parylene-c, which itself has a vastly lower modulus than the silicon or metallic 
substrates which make up the majority of current neural interface technologies. 
By using parylene-c as a control to evaluate the dynamically softening SMP 
material, this experiment provides an isolation of the effects of dynamic 
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softening capability which is superior to previous studies, and finds that this 
capability provides a beneficial reduction in the immune response.  
4.5 Conclusion 
Histological evaluation of dynamically softening polymer neural implants 
revealed significant reductions in reactive astrocyte activity compared to non-
softening parylene-c control implants. These results demonstrate that the 
dynamically softening shape memory polymer implant substrate which was 
evaluated provides a desirable reduction in reactive astrocyte encapsulation by 
reducing chronic mechanical stresses in the surrounding tissue. Encapsulation 
by reactive astrocytes is thought to be one of the primary failure modes of 
neural interfaces, and the reduction of the astrocyte response should 
correspond to an improvement in recording electrode performance.  The 
observed reduction in the astrocytic reaction suggests that the SMP system is a 
good candidate for use in future neural interfaces. Further work is needed to 
evaluate the performance of functional recording electrodes on this substrate 
and determine whether the observed reduction in reactive gliosis translates to 
improvements in recording signal quality and lifetime. The combination of the 
SMP substrate system with other mitigation strategies is another promising 
direction of future work; techniques such as chemical functionalization of the 
implant surface or manipulation of the tissue adhesion properties may prove to 
be beneficial additions. Further reductions of the softened modulus of the SMP 
system will also be pursued, in order to maximize the benefits of its dynamic 
softening capability.   
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5 General Conclusions 
5.1 Review of Main Findings 
 The overarching aims of this set of studies were to gain a better 
understanding of the immune response itself and to evaluate novel methods to 
reduce the magnitude of the brain’s immune response to implanted neural 
interfaces, in order to inform future neural interface designs and improve their 
performance. Important insights were gained into the spatial distribution of 
immune cell activity in the cortex and the influence of multiple implant design 
characteristics on various aspects of the immune response. 
 Preliminary studies not described in this dissertation found evidence of a 
pattern of decreasing immune activity with increasing depth in the cortex, and 
these findings provided motivation for the study described in Chapter 2, which 
compared the chronic immune response to conventionally implanted 
microwires, which were in chronic contact with the meninges, and that of similar 
implants placed sub-meninges. Sub-meninges implants were found to elicit 
substantially less immune activity than trans-meninges plants, as measured by 
levels of both microglia and reactive astrocytes. These findings lend further 
support to the idea of a significant meningeal contribution to the chronic 
immune response, and motivate the development of wireless interface designs 
which may be placed completely below the meninges.  
 These results provided motivation for the experiment described in 
Chapter 3, which further investigated the interaction of the implant with the 
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meningeal tissue. Porous-shank planar implants were found to significantly 
reduce meningeal tissue growth down the implant shaft compared to non-
porous implants by allowing the meningeal tissue to grow into the structure of 
the implant at or near the level of the cortical surface. Porous implants were 
also found to improve neuron density in the recording zone around the implant 
shaft, which is of vital importance to neural electrode recording performance. 
This novel implant design feature demonstrates that the meningeal portion of 
the immune response may be reduced by relatively simple means, which is 
promising and informative for the design of future neural interfaces.  
 The study described in Chapter 4 examined a new type of dynamically 
softening neural interface substrate and evaluated its immune system 
performance compared to similar implants which lacked dynamic softening 
capability. The drop in modulus was found to significantly reduce the amount of 
reactive astrocyte encapsulation around the SMP implants by creating a better 
mechanical match with the surrounding cortical tissue and thus reducing 
chronic mechanical stresses and irritation. Reduction of reactive astrocyte 
encapsulation is one of the main goals of neural interface development, and 
these findings suggest that use of the SMP substrate in future neural interface 
applications should result in an improvement in recording performance over 
existing technologies. The use of parylene-c control implants in this experiment 
allowed the isolation of the effects of dynamic softening capability to a greater 
degree than has been previously achieved, since previous work has only 
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compared dynamically softening implant substrates to implant materials which 
are significantly stiffer than the softening implant in its unsoftened state.  
 The combined results of these studies provide new insight into the 
factors governing the chronic immune response to a cortical electrode and 
suggest design features to help improve the recording performance of future 
neural interfaces. The findings of the experiments described in Chapters 2 and 
3 highlight the importance of meningeal contributions to the chronic immune 
response and demonstrate interventional strategies which have the potential to 
improve the performance of future recording devices. Previous work has not 
generally treated the meningeal and astrocytic portions of the immune reaction 
as separate, but Chapters 3 and 4, when considered together, suggest that 
these are at least somewhat independent phenomena. The addition of near-
surface pores to the implant altered the meningeal response, but not the 
astrocyte response. The addition of dynamic softening capability reduced the 
astrocyte response, which corroborates other findings relating the astrocyte 
reaction to mechanical stresses in the tissue, but did not affect the meningeal 
response. Previous work showing the tendency of meningeal cells to initiate glia 
limitans formation when in contact with astrocytes suggests that the negative 
effects of meningeal cells on recording performance may be greater than 
previously thought, since histological methods focusing on the characteristics of 
the fibrous capsule around the implant track, rather than simply the abundance 
of reactive astrocytes, are not currently available. The findings presented in this 
dissertation suggest that a greater understanding of the causes and effects of 
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meningeal cell infiltration around a cortical neural interface will be important in 
the development of future devices and the improvement of recording electrode 
performance.  
 
5.2 Future Directions 
 The focus of this body of work was to gain a better understanding of the 
factors which influence the brain's immune response to a neural implant via 
histological examination and quantification of the cells involved in the immune 
response. The reduction of these histological metrics of immune activity is, of 
course, not the ultimate goal, but simply a means to the end of improving the 
recording performance of neural interfaces. The ultimate measure of the 
techniques described in this dissertation will be their application to functional 
recording devices and examination of signal quality and lifetime. The most 
promising finding in terms the magnitude of its effect on the immune response 
was described in Chapter 2, where placement of the neural implant completely 
below the meninges provided a substantial reduction in reactive astrocyte and 
microglia activity. This finding motivates the development of a wireless 
recording probe which could be placed completely below the meninges, and 
should yield improved recording performance over current technologies. The 
findings of Chapter 4 also inform the design of such an interface, suggesting 
that the use of the SMP system for the implant substrate could provide a further 
improvement in recording capability. The findings described in Chapter 3 are 
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promising, but the ultimate test of porous-shank structures will be in their 
application in a functional recording electrode. This work has shown that the 
meningeal component of the cortical immune response is an important 
consideration of neural interface design, and further investigation of the 
meningeal response and its functional effects on neural electrodes is warranted. 
Future work could also include the combination of techniques investigated 
herein with other successful mitigation strategies, such as the addition of 
surface treatments to SMP implants to control tissue adhesion or protein 
adsorption.  Also, histological techniques which permit the examination of 
implants in situ within a thick coronal tissue section have been recently 
developed (Woolley et al., 2013) which would be particularly well suited to a 
closer examination of depth-related responses and the interaction of porous-
shank implants with the meningeal tissue. The use of this device capture 
histology technique would allow the migration of meningeal tissues to be 
examined in much more detail, and enable the optimization of the porous-shank 
design in order to minimize meningeal tissue encapsulation of the implant and 
improve recording performance.  
Neural interfacing is still a young field, and many challenges remain to be 
overcome before the ultimate goals of these technologies can be realized. 
When dealing with a system of such truly stupendous complexity as the central 
nervous system, these challenges are to be expected, but even in the time 
period over which these experiments were conducted, many significant 
advances have been made in neural interface design. This rapid pace of 
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advancement paints a bright and very exciting future for this field, and it is 
hoped that the work described herein proves to be a significant contribution 
towards the ultimate goal of clinical viability.  
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